Section 40

EurekaMag Full Text Articles Chapter 39,864


Gaines, A.D.; Schiff, S.E.; Buckley, R.H. 1991: Donor type natural killer cells after haploidentical T cell-depleted bone marrow stem cell transplantation in a patient with adenosine deaminase-deficient severe combined immunodeficiency. Clinical Immunology and Immunopathology 60(2): 299-304
Möschl, P.; Lubec, G.; Keiler, A.; Salem, G.; Glöckler, M. 1979: Donor- and organ-specific evaluation of antibodies eluted from canine lung allografts rejected by immunosuppressively treated and untreated recipients. Respiration; International Review of Thoracic Diseases 38(1): 12-17
Maruta, A.; Fukawa, H.; Kanamori, H.; Harano, H.; Noguchi, T.; Kodama, F.; Kase, N.; Matsuzaki, M.; Miyashita, H.; Motomura, S. 1991: Donor-HLA-incompatible marrow transplantation with an anti-donor cytotoxic antibody in the serum of the patient. Bone Marrow Transplantation 7(5): 397-400
Mollenhauer, J.; Bayreuther, K. 1986: Donor-age-related changes in the morphology, growth potential, and collagen biosynthesis in rat fibroblast subpopulations in vitro. Differentiation; Research in Biological Diversity 32(2): 165-172
Browne, P.V.; Lawler, M.; Humphries, P.; McCann, S.R. 1991: Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. New England Journal of Medicine 325(10): 710-713
Merikallio, E.; Mattila, S.; Tala, P. 1976: Donor-circulation as cardiopulmonary bypass in experimental heart transplantation. Scandinavian Journal of Thoracic and Cardiovascular Surgery 10(1): 63-76
Hoogerbrugge, P.M.; Suzuki, K.; Suzuki, K.; Poorthuis, B.J.; Kobayashi, T.; Wagemaker, G.; van Bekkum, D.W. 1988: Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science 239(4843): 1035-1038
Hows, J.; Beddow, K.; Gordon-Smith, E.; Branch, D.R.; Spruce, W.; Sniecinski, I.; Krance, R.A.; Petz, L.D. 1986: Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 67(1): 177-181
Häyry, P.; Leszczynski, D.; Nemlander, A.; Ferry, B.; Renkonen, R.; von Willebrand, E.; Halttunen, J. 1988: Donor-directed cytotoxic T cells and other inflammatory components of acute allograft rejection. Annals of the new York Academy of Sciences 532: 86-105
Yokoyama, Y.; Cooper, D.K.; Sasaki, H.; Snow, T.R.; Akutsu, T.; Zuhdi, N. 1992: Donor-heart evaluation by monitoring the left ventricular pressure-volume relationship: clinical observations. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 11(4 Pt 1): 685-692
Vereerstraeten, P.; Dupont, E.; Andrien, M.; De Pauw, L.; Kinnaert, P.; Toussaint, C. 1987: Donor-recipient DR antigen combinations in cadaver renal graft survival: a new approach to recipient selection. Transplantation Proceedings 19(5): 3647-3650
Donnelly, P.; Veitch, P.; Bell, P.; Henderson, R.; Oman, P.; Proud, G. 1991: Donor-recipient age difference--an independent risk factor in cyclosporin-treated renal transplant recipients. Transplant International: Official Journal of the European Society for Organ Transplantation 4(2): 88-91
Summers, C.; Fergusson, W.; Gokhale, D.; Taylor, M. 1992: Donor-recipient bone-marrow matching by single strand conformation polymorphism analysis. Lancet 339(8793): 621
Bonnette, P.; Bisson, A.; Ben el Kadi, N.; Leroy, M.; Colchen, A.; Perruchoud, A. 1992: Donor-recipient lung volume matching in double lung transplantation. Value of left lower lobe graft. Annales de Chirurgie 46(8): 673-676
Meduri, G.; Fromentin, L.; Vieillefond, A.; Fries, D. 1991: Donor-related non-Hodgkin's lymphoma in a renal allograft recipient. Transplantation Proceedings 23(5): 2649
Thomas, J.M.; Thomas, F.T.; Hoffman, S.; Johns, C.; Mendez-Picon, G.; Lee, H.M. 1979: Donor-specific CML hyporesponsiveness after successful renal transplantation: studies on the mechanism. Transplantation Proceedings 11(2): 1258-1259
Pierce, J.C.; Kay, S.; Lee, H.M. 1975: Donor-specific IgG antibody and the chronic rejection of human renal allografts. Surgery 78(1): 14-21
Bakran, A.; Taylor, G.M.; Read, I.; Fergusson, W.; Johnson, R.W. 1987: Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation. Transplantation Proceedings 19(1 Part 1): 748-749
Caillat, S.; Poisson, J.; Campos, H.; Debure, A.; Kreis, H.; Bach, J.F.; Chatenoud, L. 1987: Donor-specific T cell lines grown from fine-needle aspirates of human renal allografts during acute rejection. Transplantation 44(2): 325-329
Garcia, L.F.; Arango, A.M.; Rezonzew, R.; Correa, M.; Angel, B.; Guzman, B.; Paris, S.C.; Arbelaez, M.; Henao, J.E.; Mejia, G. 1991: Donor-specific and random transfusions in HLA-haploidentical kidney transplantation. Transplantation Proceedings 23(2): 1744-1746
Braun, W.E. 1991: Donor-specific antibodies. Clinical relevance of antibodies detected in lymphocyte crossmatches. Clinics in Laboratory Medicine 11(3): 571-602
Schulak, J.A.; Cooke, J.C.; Herrmann, M. 1990: Donor-specific antigen and cyclosporine fail to prolong rat pancreas survival. Transplantation Proceedings 22(2): 739-740
Kakizaki, K.; Didlake, R.; Basadonna, G.; Kahan, B.D.; Merrell, R.C. 1987: Donor-specific antigen and cyclosporine in rat islet allografts. Journal of Surgical Research 42(5): 494-497
Dienst, S.G.; Amprim, F.L.; Schervish, E. 1988: Donor-specific blood transfusion reduces cyclosporine effect on the survival of canine renal allografts. Transplantation Proceedings 20(3 Suppl 3): 1102-1104
Fujiwara, T.; Sakagami, K.; Haisa, M.; Kusaka, S.; Uda, M.; Kobayashi, N.; Tanakaya, K.; Saito, S.; Matsuno, T.; Matsuoka, J. 1992: Donor-specific blood transfusions (DST): clinical outcome and immunologic considerations. Transplantation Proceedings 24(4): 1427-1428
Cochrum, K.C.; Hanes, D.; Potter, D.; Vincenti, F.; Amend, W.; Feduska, N.; Perkins, H.; Salvatierra, O. 1979: Donor-specific blood transfusions in HLA-D-disparate one-haplotype-related allografts. Transplantation Proceedings 11(4): 1903-1907
Salvatierra, O.; Melzer, J.; Vincenti, F.; Amend, W.J.; Tomlanovich, S.; Potter, D.; Husing, R.; Garovoy, M.; Feduska, N.J. 1987: Donor-specific blood transfusions versus cyclosporine--the DST story. Transplantation Proceedings 19(1 Part 1): 160-166
Dickmeiss, E. 1979: Donor-specific cell-mediated cytotoxicity in renal allograft recipients. Acta Pathologica et Microbiologica Scandinavica. Section C Immunology 87(6): 371-376
Arnesen, E.; Bondevik, H. 1976: Donor-specific cellular and humoral immunity after clinical kidney transplantation. Transplantation 21(6): 489-497
Ruiz, P.; Fuller, J.; Sanfilippo, F. 1990: Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients. Transplantation 49(1): 175-183
Pfeffer, P.F.; Foerster, A.; Tveter, A.K.; Simonsen, S.; Frøysaker, T.; Thorsby, E. 1988: Donor-specific cytotoxic T cells recovered from transvenous biopsies after clinical heart transplantation. Transplantation Proceedings 20(2): 306-307
Ruiz, P.; Foulks, G.N.; Sanfilippo, F. 1989: Donor-specific cytotoxic T-cell alloreactivity in successfully engrafted high-risk cornea patients. Transplantation Proceedings 21(1 Pt 3): 3153-3155
Dal Col, R.H.; Zeevi, A.; Rabinowich, H.; Herlan, D.B.; Yousem, S.A.; Griffith, B.P. 1990: Donor-specific cytotoxicity testing: an advance in detecting pulmonary allograft rejection. Annals of Thoracic Surgery 49(5): 754-758
Greig, P.D.; Forster, J.; Superina, R.A.; Strasberg, S.M.; Mohamed, M.; Blendis, L.M.; Taylor, B.R.; Levy, G.A.; Langer, B. 1990: Donor-specific factors predict graft function following liver transplantation. Transplantation Proceedings 22(4): 2072-2073
Bas, J.; Masip, E.; Mestre, M.; Griñó, J.M.; González, C.; González, L.; Buendia, E. 1992: Donor-specific hyporesponsiveness in renal transplantation. Transplantation Proceedings 24(1): 76-77
Miltenburg, A.M.; Meijer-Paape, M.E.; Daha, M.R.; van Bockel, J.H.; Weening, J.J.; van Es, L.A.; van der Woude, F.J. 1989: Donor-specific lysis of human kidney proximal tubular epithelial cells by renal allograft-infiltrating lymphocytes. Transplantation 48(2): 296-302
Dossetor, J.B.; Kovithavongs, T.; Schlaut, J.; Pazderka, V.; Liburd, E.M.; Bettcher, K.B.; Pazderka, F. 1979: Donor-specific monitoring of transplant patients. Transplantation Proceedings 11(2): 1235-1236
Ettenger, R.B.; Opelz, G.; Walker, J.; Terasaki, P.I.; Malekzadeh, M.H.; Pennisi, A.J.; Uittenbogaart, C.H.; Fine, R.N. 1978: Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients. Transplantation Proceedings 10(2): 479-481
Mehta, R.C.; Wilson, M.A.; Perlman, S.B. 1989: Donor-specific rejection. Clinical Nuclear Medicine 14(1): 68-69
Baquerizo, A.; Kamada, N.; Millis, J.M.; Iwaki, Y.; Terasaki, P.I.; Hart, J.; Pera, C.; Busuttil, R.W. 1989: Donor-specific serum transfusion prolongs survival of orthotopic liver transplantation in the rat. Transplantation Proceedings 21(1 Pt 1): 1179-1180
Garrison, J.L.; Cunningham, P.R.; Lust, R.M.; Thomas, F.T. 1990: Donor-specific tolerance permits burn allografting without increased sepsis. Journal of Surgical Research 49(5): 390-393
Iwaki, Y.; Terasaki, P.I. 1986: Donor-specific transfusion. Clinical Transplants 1986: 267-275
Haisa, M.; Sakagami, K.; Matsumoto, T.; Kawamura, T.; Uchida, S.; Fujiwara, T.; Shiozaki, S.; Inagaki, M.; Orita, K. 1989: Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization. Transplantation Proceedings 21(1 Part 2): 1814-1817
McMillan, M.A.; Briggs, J.D.; Junor, B.J.; MacSween, R.N.; Sandilands, G.P. 1987: Donor-specific transfusion and antibody response. Lancet 1(8535): 744-745
Kaplan, E.; Dresdale, A.R.; Diehl, J.T.; Aronovitz, M.J.; Konstam, M.A.; Katzen, N.A.; Gould, K.E.; Isner, J.M.; Connolly, R.J.; Payne, D.D. 1988: Donor-specific transfusion and cardiac xenografts. Transplantation 46(4): 605-607
Cofer, B.R.; Tchervenkov, J.I.; Alexander, J.W.; Barnwell, S.C. 1991: Donor-specific transfusion and cyclosporine prolong allograft survival when given in the peroperative period. Transplantation Proceedings 23(1 Pt 1): 157-158
Belzer, F.O.; Kalayoglu, M.; Sollinger, H.W. 1987: Donor-specific transfusion in living-unrelated renal donor-recipient combinations. Transplantation Proceedings 19(1 Pt 2): 1514-1515
Górecki, D.; Jakóbisiak, M.; Lupińska, M.; Kruszewski, A.; Czyźyk, J. 1989: Donor-specific transfusion via the portal venous route induces prolongation of H-2-compatible but not H-2-incompatible cardiac graft survival. Transplant International: Official Journal of the European Society for Organ Transplantation 2(4): 199-202
Sells, R.A.; Hillis, A.; Bone, M.J.; Evans, P.; Evans, C.M.; Scott, M.M. 1988: Donor-specific transfusion with and without cyclosporine A--a controlled clinical trial. Transplantation Proceedings 20(3 Suppl 3: 270-273
Sonoda, T.; Ishibashi, M. 1987: Donor-specific transfusion: a report of the Japanese Renal Transplant Registry. Clinical Transplants 1987: 257-260
Stevens, D.W.; Jensen, C.P.; Jensen, R.M.; Stevens, L.E. 1988: Donor-specific transfusions add only in a minor degree to the effect of cyclosporine a. Transplantation Proceedings 20(3 Suppl 3: 1091-1093
Bove, S.; Gaudio, K.; Siegel, N.; Bia, M.J. 1988: Donor-specific transfusions before transplantation. A comparison of results in children and adults at the same institutions. Transplantation 45(1): 224-225
Eklund, B.; Ahonen, J.; Salmela, K.; Höckerstedt, K.; Isoniemi, H.; Koskimies, S. 1990: Donor-specific transfusions in HLA-one haplotype-matched kidney transplantation. Transplantation Proceedings 22(1): 151-152
Salvatierra, O. 1986: Donor-specific transfusions in living-related transplantation. World Journal of Surgery 10(3): 361-368
Friedman, A.; Deierhoi, M.; Chesney, R.; Sollinger, H.; Belzer, F. 1987: Donor-specific transfusions in renal transplantation in children. Effect of azathioprine plus transfusions. Transplantation 44(1): 159-161
Radvany, R.M.; Patel, K.M. 1988: Donor-specific transfusions. Donor-recipient HLA compatibility, recipient HLA haplotype, and antibody production. Transfusion 28(2): 137-141
Bushnell, A.; Pearson, T.C.; Morris, P.J.; Wood, K.J. 1991: Donor-specific unresponsiveness to cardiac allografts in the mouse: an examination of mechanisms. Transplantation Proceedings 23(1 Pt 1): 726-728
Anthuber, M.; Sudhoff, F.; Schuetz, A.; Kemkes, B.M. 1991: Donor-transmitted infections in heart transplantation--HIV, CMV, and toxoplasmosis. Transplantation Proceedings 23(5): 2634-2635
Dowling, R.D.; Zenati, M.; Yousem, S.A.; Pasculle, A.W.; Kormos, R.L.; Armitage, J.A.; Griffith, B.P.; Hardesty, R.L. 1992: Donor-transmitted pneumonia in experimental lung allografts. Successful prevention with donor antibiotic therapy. Journal of Thoracic and Cardiovascular Surgery 103(4): 767-772
Steiniger, B.; Klempnauer, J. 1986: Donor-type MHC-positive cells in the host spleen after rat organ transplantation. Differences between pancreas and heart allograft recipients. Transplantation 41(6): 787-789
Murphy, W.J.; Bennett, M.; Kumar, V.; Longo, D.L. 1992: Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation. Journal of Immunology 148(9): 2953-2960
Bettinghaus, E.P.; Milkovich, M.B. 1975: Donors and nondonors: communication and information. Transfusion 15(2): 165-169
Podmore, W. 1991: Donors and sellers of organs. Journal of Medical Ethics 17(3): 163
Starovoĭt, V.V.; Feoktistov, A.N. 1976: Donors for direct blood transfusion. Problemy Gematologii i Perelivaniia Krovi 21(12): 45-46
Kotelba-Witkowska, B.; Mrowiec, Z.R.; Daszyński, J.; Skrzeczkowska, E. 1990: Donors leukapheresis on Fenwal CS-3000. Materia Medica Polona. Polish Journal of Medicine and Pharmacy 22(1): 33-35
Noack, E.; Feelisch, M. 1989: Molecular aspects underlying the vasodilator action of molsidomine. Journal of Cardiovascular Pharmacology 14(Suppl 11): S1-S5
Gade, I.J.; Hansen, J.; Kosteljanetz, M. 1989: Donors of cadaver kidneys. Reactions of relatives illustrated by a questionnaire study. Ugeskrift for Laeger 151(51): 3476-3478
Buckner, C.D.; Sanders, J.E.; Anasetti, C.; Beatty, P.; Hansen, J.A.; Storb, R.; Clift, R.; Thomas, E.D. 1989: Donors other than HLA-identical siblings. Progress in Clinical and Biological Research 309: 383-390
Franco, E.; Picazo, J.; Mazón, C.; Antich, J.L.; Lafulla, C.; Ribó, E.; Contreras, E. 1986: Donors with positive antibodies against HIV virus in Red Cross blood banks. Sangre 31(6): 775-776
Lachiver, L.D.; Galey-Langlois, F. 1978: Donovaniasis. Soins; la Revue de Reference Infirmiere 23(24): 47-48
Duperrat, B. 1976: Donovanosis. La Revue du Praticien 26(47): 3307-3310
O'Farrell, N. 1991: Donovanosis (granuloma inguinale) in pregnancy. International Journal of Std and Aids 2(6): 447-448
Faber, B.L. 1987: Donovanosis (granuloma inguinale) in the Orange Free State. South African Medical Journal 71(3): 196
Garg, B.R.; Lal, S.; Bedi, B.M.; Ratnam, D.V.; Naik, D.N. 1975: Donovanosis (granuloma inguinale) of the oral cavity. British Journal of Venereal Diseases 51(2): 136-137
Maddocks, I.; Anders, E.M.; Dennis, E. 1976: Donovanosis in Papua new Guinea. British Journal of Venereal Diseases 52(3): 190-196
Silva, D.; Salgado, U.; Macêdo, C.; Neves, C. 1991: Donovanosis in Pará. Revista da Sociedade Brasileira de Medicina Tropical 24(4): 251-252
Richens, J. 1985: Donovanosis--a review. Papua and New Guinea Medical Journal 28(2): 67-74
Marchand, C.; Fayol, D.; Gaboriaux, M.C.; Thivolet, J. 1986: Donovanosis. Apropos of a new case of granuloma inguinale in France. Annales de Medecine Interne 137(8): 656-659
Ena, P.; Fiori, P.L.; Zanetti, S. 1988: Donovanosis. Presentation of a case. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 123(4): 167-169
Haussmann, H. 1975: Dontisolon-P-oral medicated paste in periodontal electrosurgery. Zwr 84(19): 870-873
Carlson, J.W. 1989: Donum Vitae on homologous interventions: is IVF-ET a less acceptable gift than "GIFT"?. Journal of Medicine and Philosophy 14(5): 523-540
Byk, C. 1989: Donum Vitae: civil law and moral values. Journal of Medicine and Philosophy 14(5): 561-573
Breathnach, C.S.; Doolin, W. 1987: Doolin. Irish Medical Journal 80(7): 213
LoPresti, G.A. 1988: Doom and gloom in medicine. Journal of the Florida Medical Association 75(10): 663-664
Silber, T.; D'Angelo, L. 1987: Doom anxiety and Hoigne's syndrome. American Journal of Psychiatry 144(10): 1365
Maxwell, R.J. 1979: Doomed status: observations on the segregation of impaired old people. Psychiatric Quarterly 51(1): 3-14
Webber-Jones, J. 1992: Doomed to deafness?. American Journal of Nursing 92(11): 37-39
Smith, D.R. 1990: Dooming animals to no life at all?. Journal of the American Veterinary Medical Association 196(6): 833
Eirew, H.L. 1977: Doomsday dentistry. Probe 19(5): 190
Erickson, D. 1992: Doomsday diagnostic?. Scientific American 267(2): 120
Schall, R.; Padayachee, N. 1990: Doomsday forecasts of the AIDS epidemic. South African Medical Journal 78(9): 503
O'Farrell, N. 1991: Doomsday forecasts of the AIDS epidemic--whither Durban?. South African Medical Journal 79(9): 566
Pittman, J.A. 1985: Doomsday: Friday the 13th of November, 1987 or Out of gas, the end of the world is coming. Alabama Medicine: Journal of the Medical Association of the State of Alabama 54(7): 20-4 26-7
Dreyer, R. 1991: Door openers. Adding to your education can be a plus. Rdh 11(3): 20
Cutts, F.T.; Phillips, M.; Kortbeek, S.; Soares, A. 1990: Door-to-door canvassing for immunization program acceleration in Mozambique: achievements and costs. International Journal of Health Services: Planning Administration Evaluation 20(4): 717-725
Meneghini, F.; Rocca, W.A.; Grigoletto, F.; Morgante, L.; Reggio, A.; Savettieri, G.; Di Perri, R.; Anderson, D.W. 1991: Door-to-door prevalence survey of neurological diseases in a Sicilian population. Background and methods. the Sicilian Neuro-Epidemiologic Study (SNES) Group. Neuroepidemiology 10(2): 70-85
Devisch, R.; Vervaeck, B. 1986: Doors and thresholds: Jeddi's approach to psychiatric disorders. Social Science and Medicine 22(5): 541-551
García Nieto, V.; López Mendoza, S.; del Castillo, L.O.; Rodríguez Rodríguez, I. 1985: Doors syndrome. Anales Espanoles de Pediatria 22(4): 338
Samuel, S.A. 1985: Doorway to quality nursing care. Nursing Journal of India 76(5): 113
Telford, N.; May, P.C.; Sinha, Y.N.; Porter, J.C.; Finch, C.E. 1992: Dopa accumulates in the hypothalamic-hypophysial portal vessels and is taken into the anterior pituitary of NSD-1015-treated rodents. Neuroendocrinology 55(4): 390-395
Zarifian, E. 1979: Dopa and dopamine agonists in depression. L'Encephale 5(5 Suppl): 665-670
Townsend, D.W.; Olds, D.P.; King, R.A. 1986: Dopa oxidase activity in human hair bulbs measured by high-performance liquid chromatography. Journal of Investigative Dermatology 86(5): 570-572
Scott, P.V.; de Jong, M. 1989: Tetrahydroaminoacridine in Alzheimer's disease. Bmj 298(6682): 1250-1251
Lamberti, P.; de Mari, M.; Iliceto, G.; Federico, F. 1992: Dopa responsive dystonia and juvenile Parkinson's disease: two subtypes of the same disorder?. Acta Neurologica 14(4-6): 451-454
Boyd, K.; Patterson, V. 1989: Dopa responsive dystonia: a treatable condition misdiagnosed as cerebral palsy. Bmj 298(6679): 1019-1020
Hutton, I.M.; Tebbutt, S.; Castro, J.E. 1977: Dopa uptake by human melanomas maintained in immunosuppressed mice. Clinical Oncology 3(3): 271-280
Januszewicz, W.; Wocial, B. 1975: Dopa, catecholamines and their metabolites in essential hypertension. Clinical Science and Molecular Medicine. Suppl 2: 295s-298s
Chen, S. 1992: Dopa-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated hemiparkinsonian monkeys. Zhonghua Shen Jing Jing Shen Ke Za Zhi 25(1): 50
Quinn, N.P. 1991: Dopa-responsive dystonia. Developmental Medicine and Child Neurology 33(8): 750
Micheli, F.; Pardal, M.F.; Gatto, E.; Paradiso, G. 1991: Dopa-responsive dystonia masquerading as idiopathic kyphoscoliosis. Clinical Neuropharmacology 14(4): 367-371
Sawle, G.V.; Leenders, K.L.; Brooks, D.J.; Harwood, G.; Lees, A.J.; Frackowiak, R.S.; Marsden, C.D. 1991: Dopa-responsive dystonia: [18F]dopa positron emission tomography. Annals of Neurology 30(1): 24-30
Nygaard, T.G.; Marsden, C.D.; Fahn, S. 1991: Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 41(2): 174-181
Nygaard, T.G.; Trugman, J.M.; de Yebenes, J.G.; Fahn, S. 1990: Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 40(1): 66-69
Lang, A.E.; Garnett, E.S. 1990: Dopa-responsive parkinsonism with normal 6[18F]-fluorodopa positron emission tomography scans. Annals of Neurology 28(4): 592-593
Blin, O.; Ferrandez, A.M.; Pailhous, J.; Serratrice, G. 1991: Dopa-sensitive and dopa-resistant gait parameters in Parkinson's disease. Journal of the Neurological Sciences 103(1): 51-54
Giroud, M.; Septien, L.; Couillault, G.; Gras, P.; Nivelon, J.L.; Dumas, R. 1992: Dopa-sensitive muscular dystonia. Segawa's syndrome. A case report. Annales de Pediatrie 39(4): 248-250
Bing, R.J. 1992: Dopa: then and now. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 6(12): 3122
Tanaka, T.; Furukawa, T. 1975: Dopamin beta-hydroxylase (DBH). Masui. Japanese Journal of Anesthesiology 24(9): 847-852
Spohr, U.; Ritz, F.; Kaden, F. 1977: Dopamin-beta-hydroxylaseaktivität im Plasma von Dialysepatienten. Klinische Wochenschrift 55(22): 1089-1093
Janda, A. 1976: Dopamin-therapy for acute postoperative renal failure. Praktische Anasthesie Wiederbelebung und Intensivtherapie 11(1): 33-38
Withy, R.M.; Mayer, R.J.; Strange, P.G. 1979: Dopamine (3,4-dihydroxyphenethylamine) receptor binding in subcellular fractions from bovine caudate. Biochemical Society Transactions 7(2): 414-416
Taraskevich, P.S.; Douglas, W.W. 1990: Dopamine (D2) or gamma-aminobutyric acid (GABAB) receptor activation hyperpolarizes rat melanotrophs and pertussis toxin blocks these responses and the accompanying fall in [Ca2+]i. Neuroscience Letters 112(2-3): 205-209
Hjorth, S.; Clark, D.; Carlsson, A. 1988: Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation. European Journal of Pharmacology 152(3): 207-215
Anonymous 1978: Dopamine (intropin). Drug and Therapeutics Bulletin 16(20): 79-80
Cagossi, M.; Pigliucci, G.M.; Ruvolo, M.R.; Porcelli, G. 1979: Dopamine 17-beta-hydroxylase in chronic uremic patients under periodic hemodialytic treatment. Chirurgia E Patologia Sperimentale 27(6): 579-589
Huq, A.H.; Matsuoka, S.; Kurahashi, Y.; Kuroda, Y.; Ma, S.J.; Ohuchi, T.; Oka, M. 1988: Dopamine 4-sulfate: effects on isolated perfused rat heart and role of atria. Life Sciences 43(20): 1599-1606
Van Wimersma Greidanus, T.B.; Maigret, C.; Torn, M.; Ronner, E.; Van der Kracht, S.; Van der Wee, N.J.; Versteeg, D.H. 1989: Dopamine D-1 and D-2 receptor agonists and antagonists and neuropeptide-induced excessive grooming. European Journal of Pharmacology 173(2-3): 227-231
Kiritsy-Roy, J.A.; Standish, S.M.; Terry, L.C. 1989: Dopamine D-1 and D-2 receptor antagonists potentiate analgesic and motor effects of morphine. Pharmacology Biochemistry and Behavior 32(3): 717-721
Miller, R.; Wickens, J.R.; Beninger, R.J. 1990: Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs. Progress in Neurobiology 34(2): 143-183
Koshikawa, N.; Tomiyama, K.; Omiya, K.; de Beltrán, K.K.; Kobayashi, M. 1990: Dopamine D-1 but not D-2 receptor stimulation of the dorsal striatum potentiates apomorphine-induced jaw movements in rats. European Journal of Pharmacology 178(2): 189-194
Fabbrini, G.; Braun, A.; Mouradian, M.M.; Tamminga, C.A.; Chase, T.N. 1988: Dopamine D-1 receptor agonist stimulation of prolactin secretion in man. Journal of Neural Transmission 71(3): 159-163
Cash, R.; Raisman, R.; Ploska, A.; Agid, Y. 1987: Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease. Journal of Neurochemistry 49(4): 1075-1083
Sasa, M.; Hara, M.; Takaori, S. 1991: Dopamine D-1 receptor-mediated inhibition of nucleus accumbens neurons from the ventral tegmental area. Progress in Neuro-Psychopharmacology and Biological Psychiatry 15(1): 119-128
Rinne, J.O.; Rinne, J.K.; Laakso, K.; Lönnberg, P.; Rinne, U.K. 1985: Dopamine D-1 receptors in the parkinsonian brain. Brain Research 359(1-2): 306-310
Ljungberg, T. 1989: Dopamine D-2 antagonists reverse apomorphine-induced decreased water intake in the rat: prediction of antipsychotic drugs with few extrapyramidal side-effects?. Journal of Neural Transmission 76(2): 79-90
Filloux, F.M.; Wamsley, J.K.; Dawson, T.M. 1987: Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride. European Journal of Pharmacology 138(1): 61-68
Kung, H.F.; Kasliwal, R.; Pan, S.G.; Kung, M.P.; Mach, R.H.; Guo, Y.Z. 1988: Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide. Journal of Medicinal Chemistry 31(5): 1039-1043
McDougall, S.A.; Nonneman, A.J. 1989: Dopamine D-2 receptor mediation of response suppression learning of young rats. Developmental Psychobiology 22(3): 235-256
Ohno, Y.; Sasa, M.; Takaori, S. 1985: Dopamine D-2 receptor-mediated excitation of caudate nucleus neurons from the substantia nigra. Life Sciences 37(16): 1515-1521
Jarvie, K.R.; Niznik, H.B.; Seeman, P. 1987: Dopamine D-2 receptors in canine brain: ionic effects on [3H]neuroleptic binding. European Journal of Pharmacology 144(2): 163-171
Joyce, J.N.; Loeschen, S.K.; Marshall, J.F. 1985: Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation. Brain Research 338(2): 209-218
Bagetta, G.; Priolo, E.; Nistico, G. 1988: Dopamine D-2 receptors in the ventral tegmental area mediate behavioural and electrocortical sleep of dopaminergic drugs in rats. Pharmacological Research Communications 20(12): 1091-1092
Kelly, E.; Nahorski, S.R. 1987: Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain. Naunyn-Schmiedeberg's Archives of Pharmacology 335(5): 508-512
Casey, D.E. 1992: Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys. Psychopharmacology 107(1): 18-22
Sickles, A.E.; Stehouwer, D.J.; Van Hartesveldt, C. 1992: Dopamine D1 and D2 antagonists block L-dopa-elicited air-stepping in neonatal rats. Brain Research. Developmental Brain Research 68(1): 17-22
Callahan, P.M.; Appel, J.B.; Cunningham, K.A. 1991: Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology 103(1): 50-55
Maslowski, R.J.; Napier, T.C. 1991: Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons. European Journal of Pharmacology 200(1): 103-112
Elliott, P.J.; Walsh, D.M.; Close, S.P. 1992: Dopamine D1 and D2 receptor interactions in the MPTP-treated marmoset. Neuroscience Letters 142(1): 1-4
Seeman, P.; Ulpian, C. 1988: Dopamine D1 and D2 receptor selectivities of agonists and antagonists. Advances in Experimental Medicine and Biology 235: 55-63
Seeman, P.; Guan, H.C. 1987: Dopamine D1 and D2 receptors are sensitive to the cationic form of apomorphine. Molecular Pharmacology 32(6): 760-763
Pascual, J.; Berciano, J.; Grijalba, B.; del Olmo, E.; González, A.M.; Figols, J.; Pazos, A. 1992: Dopamine D1 and D2 receptors in progressive supranuclear palsy: an autoradiographic study. Annals of Neurology 32(5): 703-707
Costentin, J.; Duterte-Boucher, D.; Panissaud, C.; Michael-Titus, A. 1990: Dopamine D1 and D2 receptors mediate opposite effects of apomorphine on the body temperature of reserpinized mice. Neuropharmacology 29(1): 31-35
Barone, P.; Palma, V.; DeBartolomeis, A.; Tedeschi, E.; Muscettola, G.; Campanella, G. 1991: Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine. European Journal of Pharmacology 195(1): 157-162
Camps, M.; Ambrosio, S.; Ballarin, M.; Reiriz, J.; Blesa, R.; Mahy, N. 1989: Dopamine D1 and D2 receptors visualized in MPTP treated C57 mice by in vitro autoradiography: lack of evidence of receptor modifications in parkinsonian mice. Pharmacology and Toxicology 65(3): 169-174
Fadda, P.; Martellotta, M.C.; De Montis, M.G.; Gessa, G.L.; Fratta, W. 1992: Dopamine D1 and opioid receptor binding changes in the limbic system of sleep deprived rats. Neurochemistry International 20 Suppl: 153s-156s
Meyer, M.E.; Cottrell, G.A.; Van Hartesveldt, C. 1992: Dopamine D1 antagonists potentiate the durations of bar and cling catalepsy and the dorsal immobility response in rats. Pharmacology Biochemistry and Behavior 41(3): 507-510
Teicher, M.H.; Gallitano, A.L.; Gelbard, H.A.; Evans, H.K.; Marsh, E.R.; Booth, R.G.; Baldessarini, R.J. 1991: Dopamine D1 autoreceptor function: possible expression in developing rat prefrontal cortex and striatum. Brain Research. Developmental Brain Research 63(1-2): 229-235
Ohta, K.; Graybiel, A.M.; Roffler-Tarlov, S. 1989: Dopamine D1 binding sites in the striatum of the mutant mouse weaver. Neuroscience 28(1): 69-82
Hietala, J.; Lappalainen, J.; Koulu, M.; Syvälahti, E. 1990: Dopamine D1 receptor antagonism in schizophrenia: is there reduced risk of extrapyramidal side-effects?. Trends in Pharmacological Sciences 11(10): 406-410
Neal, B.S.; Joyce, J.N. 1991: Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development. Brain Research. Developmental Brain Research 60(2): 105-113
Gelbard, H.A.; Teicher, M.H.; Baldessarini, R.J.; Gallitano, A.; Marsh, E.R.; Zorc, J.; Faedda, G. 1990: Dopamine D1 receptor development depends on endogenous dopamine. Brain Research. Developmental Brain Research 56(1): 137-140
Murrin, L.C.; Zeng, W.Y. 1989: Dopamine D1 receptor development in the rat striatum: early localization in striosomes. Brain Research 480(1-2): 170-177
Aiso, M.; Shigematsu, K.; Kebabian, J.W.; Potter, W.Z.; Cruciani, R.A.; Saavedra, J.M. 1987: Dopamine D1 receptor in rat brain: a quantitative autoradiographic study with 125I-SCH 23982. Brain Research 408(1-2): 281-285
Barone, P.; Parashos, S.A.; Palma, V.; Marin, C.; Campanella, G.; Chase, T.N. 1990: Dopamine D1 receptor modulation of pilocarpine-induced convulsions. Neuroscience 34(1): 209-217
Damsma, G.; Tham, C.S.; Robertson, G.S.; Fibiger, H.C. 1990: Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat. European Journal of Pharmacology 186(2-3): 335-338
Steffey, M.E.; Snyder, G.L.; Barrett, R.W.; Fink, J.S.; Ackerman, M.; Adams, P.; Bhatt, R.; Gomez, E.; MacKenzie, R.G. 1991: Dopamine D1 receptor stimulation of cyclic AMP accumulation in COS-1 cells. European Journal of Pharmacology 207(4): 311-317
Niznik, H.B.; Otsuka, N.Y.; Dumbrille-Ross, A.; Grigoriadis, D.; Tirpak, A.; Seeman, P. 1986: Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor. Journal of Biological Chemistry 261(18): 8397-8406
Kurumiya, S.; Nakajima, S. 1988: Dopamine D1 receptors in the nucleus accumbens: involvement in the reinforcing effect of tegmental stimulation. Brain Research 448(1): 1-6
Spooren, W.P.; Piosik, P.A.; Cools, A.R. 1991: Dopamine D1 receptors in the sub-commissural part of the globus pallidus and their role in oro-facial dyskinesia in cats. European Journal of Pharmacology 204(2): 217-222
Reader, T.A.; Grondin, L.; Montreuil, B.; Dewar, K.M. 1989: Dopamine D1 receptors labelled with [3H]SCH23390 in rabbit cerebral cortex and neostriatum. Equilibrium binding, kinetics and selectivity. Naunyn-Schmiedeberg's Archives of Pharmacology 340(6): 617-625
Niznik, H.B.; Fogel, E.L.; Chen, C.J.; Congo, D.; Brown, E.M.; Seeman, P. 1988: Dopamine D1 receptors of the calf parathyroid gland: identification and characterization. Molecular Pharmacology 34(1): 29-36
Niznik, H.B.; Jarvie, K.R.; Brown, E.M. 1989: Dopamine D1 receptors of the calf parathyroid gland: identification of a ligand binding subunit with lower apparent molecular weight but similar primary structure to neuronal D1-receptors. Biochemistry 28(17): 6925-6930
Bzowej, N.H.; Niznik, H.B.; Seeman, P. 1988: Dopamine D1 receptors with enhanced agonist affinity and reduced antagonist affinity revealed by chemical modification. Biochemical and Biophysical Research Communications 152(2): 933-939
Sedvall, G.; Farde, L.; Stone-Elander, S.; Halldin, C. 1986: Dopamine D1-receptor binding in the living human brain. Advances in Experimental Medicine and Biology 204: 119-124
Sasa, M.; Akaike, A.; Ohno, Y.; Hara, M.; Takaori, S. 1991: Dopamine D1/D2 receptor interaction. Japanese Journal of Psychiatry and Neurology 45(2): 507-510
Hietala, J.; Syvälahti, E.; Röyttä, M. 1989: Dopamine D2 and muscarinic receptor binding characteristics in rat brain after withdrawal of subchronic fluphenazine and sulpiride treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 13(1-2): 247-258
Nishino, S.; Arrigoni, J.; Valtier, D.; Miller, J.D.; Guilleminault, C.; Dement, W.C.; Mignot, E. 1991: Dopamine D2 mechanisms in canine narcolepsy. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 11(9): 2666-2671
Yang, C.R.; Bourque, C.W.; Renaud, L.P. 1991: Dopamine D2 receptor activation depolarizes rat supraoptic neurones in hypothalamic explants. Journal of Physiology 443: 405-419
Palacios, J.M.; Wiederhold, K.H. 1985: Dopamine D2 receptor agents, but not dopamine D1, modify brain glucose metabolism. Brain Research 327(1-2): 390-394
Rogue, P.; Vincendon, G. 1992: Dopamine D2 receptor antagonists induce immediate early genes in the rat striatum. Brain Research Bulletin 29(3-4): 469-472
Quik, M.; Bergeron, L.; Mount, H.; Philie, J. 1987: Dopamine D2 receptor binding in adrenal medulla: characterization using [3H]spiperone. Biochemical Pharmacology 36(21): 3707-3713
Lahti, R.A.; Evans, D.L.; Figur, L.M.; Carrigan, K.J.; Moon, M.W.; Hsi, R.S. 1991: Dopamine D2 receptor binding properties of [3H]U-86170, a dopamine receptor agonist. European Journal of Pharmacology 202(2): 289-291
Seeman, P.; Watanabe, M.; Grigoriadis, D.; Tedesco, J.L.; George, S.R.; Svensson, U.; Nilsson, J.L.; Neumeyer, J.L. 1985: Dopamine D2 receptor binding sites for agonists. a tetrahedral model. Molecular Pharmacology 28(5): 391-399
Smiałowski, A. 1991: Dopamine D2 receptor blocking effect of imipramine in the rat hippocampus. Pharmacology Biochemistry and Behavior 39(1): 105-108
Guttman, M.; Seeman, P. 1987: Dopamine D2 receptor density in parkinsonian brain is constant for duration of disease, age, and duration of L-dopa therapy. Advances in Neurology 45: 51-57
Guttman, M.; Seeman, P.; Reynolds, G.P.; Riederer, P.; Jellinger, K.; Tourtellotte, W.W. 1986: Dopamine D2 receptor density remains constant in treated Parkinson's disease. Annals of Neurology 19(5): 487-492
Seeman, P.; Grigoriadis, D. 1985: Dopamine D2 receptor dissociation constant for spiperone: identical values using 3H-labeled agonist or 3H-labeled antagonist. Biochemical Pharmacology 34(22): 4065-4066
Weathersby, R.T.; Appel, J.B. 1986: Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole). European Journal of Pharmacology 132(1): 87-91
Pizzi, M.; D'Agostini, F.; Da Prada, M.; Spano, P.F.; Haefely, W.E. 1987: Dopamine D2 receptor stimulation decreases the inositol trisphosphate level of rat striatal slices. European Journal of Pharmacology 136(2): 263-264
Keja, J.A.; Stoof, J.C.; Kits, K.S. 1992: Dopamine D2 receptor stimulation differentially affects voltage-activated calcium channels in rat pituitary melanotropic cells. Journal of Physiology 450: 409-435
Pizzi, M.; Da Prada, M.; Valerio, A.; Memo, M.; Spano, P.F.; Haefely, W.E. 1988: Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. Brain Research 456(2): 235-240
Todd, R.D.; Mack, K.J.; Gandelman, K.Y.; Hickok, J.M.; O'Malley, K.L. 1992: Dopamine D2 receptor subtypes couple to different second messenger systems. Neurochemistry International 20 Suppl: 23s-26s
Rooney, K.F.; Sewell, R.D.; Spencer, P.S.; Stolz, J.F. 1986: Dopamine D2 receptors and SCH 23390 treatment. Lancet 2(8506): 578
Hasegawa, Y.; Kurachi, M.; Otomo, S. 1990: Dopamine D2 receptors and spinal cord excitation in mice. European Journal of Pharmacology 184(2-3): 207-212
Schimchowitsch, S.; Palacios, J.M.; Stoeckel, M.E.; Porte, A. 1986: Dopamine D2 receptors are restricted to the prolactin cells in the rabbit pituitary gland: a combined autoradiographic and immunocytochemical study. Neuroscience Letters 70(3): 314-319
Von Euler, G.; von Euler, A. 1991: Dopamine D2 receptors attenuate phosphatidylinositol 4,5-bisphosphate in synaptosomal membranes from rat neostriatum. Journal of Neurochemistry 56(1): 136-140
Merchant, K.M.; Bush, L.G.; Gibb, J.W.; Hanson, G.R. 1989: Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain. Brain Research 500(1-2): 21-29
George, S.R.; Watanabe, M.; Seeman, P. 1985: Dopamine D2 receptors in brain and anterior pituitary recognize agonist and antagonist actions of (-)-3-PPP. Journal of Neural Transmission 64(1): 13-33
Crawley, J.C.; Owens, D.G.; Crow, T.J.; Poulter, M.; Johnstone, E.C.; Smith, T.; Oldland, S.R.; Veall, N.; Owen, F.; Zanelli, G.D. 1986: Dopamine D2 receptors in schizophrenia studied in vivo. Lancet 2(8500): 224-225
George, S.R.; Watanabe, M.; Seeman, P. 1985: Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states. Journal of Neurochemistry 44(4): 1168-1177
Lidow, M.S.; Goldman-Rakic, P.S.; Rakic, P.; Innis, R.B. 1989: Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride. Proceedings of the National Academy of Sciences of the United States of America 86(16): 6412-6416
Yang, R.H.; Igarashi, Y.; Wyss, J.M.; Chen, Y.F. 1990: Dopamine D2 receptors in the posterior region of the nucleus tractus solitarius mediate the central pressor action of quinpirole (LY171555). Brain Research Bulletin 24(1): 97-103
Charuchinda, C.; Supavilai, P.; Karobath, M.; Palacios, J.M. 1987: Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high-affinity selective agonist ligand. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 7(5): 1352-1360
Köhler, C.; Ericson, H.; Högberg, T.; Halldin, C.; Chan-Palay, V. 1991: Dopamine D2 receptors in the rat, monkey and the post-mortem human hippocampus. An autoradiographic study using the novel D2-selective ligand 125I-NCQ 298. Neuroscience Letters 125(1): 12-14
Liskowsky, D.R.; Potter, L.T. 1987: Dopamine D2 receptors in the striatum and frontal cortex following chronic administration of haloperidol. Neuropharmacology 26(5): 481-483
Kaseda, Y.; Ghetti, B.; Low, W.C.; Richter, J.A.; Simon, J.R. 1987: Dopamine D2 receptors increase in the dorsolateral striatum of weaver mutant mice. Brain Research 422(1): 178-181
Dewar, K.M.; Montreuil, B.; Grondin, L.; Reader, T.A. 1989: Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity. Journal of Pharmacology and Experimental Therapeutics 250(2): 696-706
Niznik, H.B.; Dumbrille-Ross, A.; Guan, J.H.; Neumeyer, J.L.; Seeman, P. 1985: Dopamine D2 receptors photolabeled by iodo-azido-clebopride. Neuroscience Letters 55(3): 267-272
Seeman, P.; Niznik, H.B. 1986: Dopamine D2 receptors photolabelled by [3H]azido-methylspiperone. European Journal of Pharmacology 127(3): 297-299
Jarvie, K.R.; Niznik, H.B.; Bzowej, N.H.; Seeman, P. 1988: Dopamine D2 receptors retain agonist high-affinity form and guanine nucleotide sensitivity after removal of sialic acid. Journal of Biochemistry 104(5): 791-794
Niznik, H.B.; Grigoriadis, D.E.; Pri-Bar, I.; Buchman, O.; Seeman, P. 1985: Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2. Naunyn-Schmiedeberg's Archives of Pharmacology 329(4): 333-343
Johnson, E.A.; Tsai, C.E.; Lucci, J.; Harrison-Shahan, Y.; Azzaro, A.J. 1992: Dopamine D2 synthesis-modulating receptors are present in the striatum of the guinea pig. Neuropharmacology 31(1): 95-101
Krotowska, A.; Nordvall, G.; Mellin, C.; Johansson, A.M.; Hacksell, U. 1987: Dopamine D2-receptor affinities of resolved C1-dimethylated 2-aminotetralins. Acta Pharmaceutica Suecica 24(4): 145-152
Matsunaga, T.; Ohara, K.; Natsukari, N.; Fujita, M. 1991: Dopamine D2-receptor mRNA level in rat striatum after chronic haloperidol treatment. Neuroscience Research 12(3): 440-445
Autelitano, D.J.; Snyder, L.; Sealfon, S.C.; Roberts, J.L. 1989: Dopamine D2-receptor messenger RNA is differentially regulated by dopaminergic agents in rat anterior and neurointermediate pituitary. Molecular and Cellular Endocrinology 67(1): 101-105
Nunes, J.L.; Sharif, N.A.; Michel, A.D.; Whiting, R.L. 1991: Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists. Neurochemical Research 16(10): 1167-1174
Ricci, A.; Rossodivita, A.; Amenta, F. 1991: Dopamine DA-2 receptor sites in the rat renal cortex: a light microscope autoradiographic study. Naunyn-Schmiedeberg's Archives of Pharmacology 344(2): 259-261
Wang, Y.X.; Gellai, M.; Brooks, D.P. 1992: Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats. American Journal of Physiology 262(6 Part 2): F1055-F1060
Facchinetti, F.; Perez-Fernandez, R.; Toma, M.O.; Gaudiero, G.J.; Lechuga, M.J.; Devesa, J.; Genazzani, A.R. 1988: Dopamine acts on acetylation of proopiomelanocortin-derived products in dog pituitary. Acta Endocrinologica 117(1): 33-38
Connell, J.M.; Tonolo, G.; Davies, D.L.; Finlayson, J.; Ball, S.G.; Inglis, G.; Fraser, R. 1987: Dopamine affects angiotensin II-induced steroidogenesis by altering clearance of the peptide in man. Journal of Endocrinology 113(1): 139-146
Lledo, P.M.; Legendre, P.; Zhang, J.; Israel, J.M.; Vincent, J.D. 1989: Dopamine affects two voltage-dependent K+ currents of identified rat lactotroph cells. Pflugers Archiv: European Journal of Physiology 414(Suppl 1): S160-S161
Smith, C.F.; Cutts, S. 1990: Dopamine agonist activity of 8-OH-DPAT. Archives Internationales de Pharmacodynamie et de Therapie 306: 106-113
Martin, G.E.; Pettibone, D.J. 1985: Dopamine agonist activity of EMD 23,448. Journal of Neural Transmission 61(1-2): 115-123
Dumbrille-Ross, A.; Seeman, P. 1987: Dopamine agonist high-affinity state in solubilized D2 receptors in striatum, but not in anterior pituitary. Biochemical Pharmacology 36(13): 2095-2099
Goldstein, M.; Kuga, S.; Kusano, N.; Meller, E.; Dancis, J.; Schwarcz, R. 1986: Dopamine agonist induced self-mutilative biting behavior in monkeys with unilateral ventromedial tegmental lesions of the brainstem: possible pharmacological model for Lesch-Nyhan syndrome. Brain Research 367(1-2): 114-120
Ahlskog, J.E.; Muenter, M.D.; Bailey, P.A.; Stevens, P.M. 1992: Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide). Archives of Neurology 49(5): 560-568
Tamminga, C.A.; Gotts, M.D.; Thaker, G.K.; Alphs, L.D.; Foster, N.L. 1986: Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine. Archives of General Psychiatry 43(4): 398-402
Clemens, B. 1988: Dopamine agonist treatment of self-induced pattern-sensitive epilepsy. A case report. Epilepsy Research 2(5): 340-343
Enz, A.; Goldstein, M.; Meller, E. 1990: Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum. Molecular Pharmacology 37(4): 560-565
Breese, G.R.; Napier, T.C.; Mueller, R.A. 1985: Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. Journal of Pharmacology and Experimental Therapeutics 234(2): 447-455
Hartgraves, S.L.; Randall, P.K. 1986: Dopamine agonist-induced stereotypic grooming and self-mutilation following striatal dopamine depletion. Psychopharmacology 90(3): 358-363
Farjo, I.B.; McQueen, J.K. 1979: Dopamine agonists and cobalt-induced epilepsy in the rat. British Journal of Pharmacology 67(3): 353-360
Maj, J. 1977: Dopamine agonists and interaction with other neurotransmitter systems. Naunyn-Schmiedeberg's Archives of Pharmacology 297(Suppl 1): S53-S54
Rosse, R.; Ciolino, C. 1985: Dopamine agonists and neuroleptic malignant syndrome. American Journal of Psychiatry 142(2): 270-271
Jeziorski, M.; White, F.J. 1989: Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors. Synapse 4(4): 267-280
Mantle, M.; Thakore, E.; Mathison, R.; Davison, J.S. 1991: Intestinal mucin secretion in streptozotocin-diabetic rats: lack of response to cholinergic stimulation and cholera toxin. Digestive Diseases and Sciences 36(11): 1574-1581
King, D.J. 1978: Dopamine agonists for negative symptoms in schizophrenia. British Journal of Clinical Pharmacology 6(6): 541-542
Mattox, J.H. 1985: Dopamine agonists in hyperprolactinemia. Fertility and Sterility 44(4): 555-557
Kapfhammer, H.P.; Rüther, E. 1985: Dopamine agonists in the therapy of parkinson syndrome. Der Nervenarzt 56(2): 69-81
Lang, A.E. 1985: Dopamine agonists in the treatment of dystonia. Clinical Neuropharmacology 8(1): 38-57
Del Zompo, M.; Bocchetta, A.; Piccardi, M.P.; Corsini, G.U. 1986: Dopamine agonists in the treatment of schizophrenia. Progress in Brain Research 65: 41-48
Kannari, K.; Markstein, R. 1991: Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted mice. Journal of Neural Transmission. General Section 84(3): 211-220
Ross, S.T.; Franz, R.G.; Gallagher, G.; Brenner, M.; Wilson, J.W.; DeMarinis, R.M.; Hieble, J.P.; Sarau, H.M. 1987: Dopamine agonists related to 3-allyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzaz epi ne-7, 8-diol. 6-Position modifications. Journal of Medicinal Chemistry 30(1): 35-40
List, S.J.; Seeman, P. 1979: Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats. Life Sciences 24(16): 1447-1452
Obeso, J.A.; Artieda, J.; Tuñón, T.; Luquin, M.R.; Martínez Lage, J.M. 1985: Dopamine agonists suppress visual-cortical reflex myoclonus. Journal of Neurology Neurosurgery and Psychiatry 48(12): 1277-1283
Lieberman, A. 1992: Dopamine agonists used as monotherapy in de novo PD patients: comparisons with selegiline. Neurology 42(4 Suppl 4: 37-40; Discussion: 41-48
Cannon, J.G. 1985: Dopamine agonists: structure-activity relationships. Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 29: 303-414
Rehse, K.; Schulte-Sienbeck, H.; Schmiechen, R.; Horowski, R. 1978: Dopamine analogous 1,2,3,4-tetrahydro-beta-carbolines. Archiv der Pharmazie 311(1): 11-18
Yasui, S.; Yamada, M.; Djamgoz, M.B. 1990: Dopamine and 2-amino-4-phosphonobutyrate differentially modify spectral responses of H1 horizontal cells in carp retina. Experimental Brain Research 83(1): 79-84
Fukuda, M.; Ono, T.; Nakamura, K.; Tamura, R. 1990: Dopamine and ACh involvement in plastic learning by hypothalamic neurons in rats. Brain Research Bulletin 25(1): 109-114
Tecce, J.J. 1991: Dopamine and CNV: studies of drugs, disease and nutrition. Electroencephalography and Clinical Neurophysiology. Suppl 42: 153-164
Cawthorpe, D.; Lukowiak, K. 1990: Dopamine and FMRFamide act directly on isolated gill muscle fibers in culture. Neuroscience Letters 113(3): 345-348
Lam, B.K.; Stier, C.T.; Wynn, N.C.; Itskovitz, H.D. 1986: Dopamine and L-dopa potentiation of pressor responses to norepinephrine in isolated perfused rat kidneys. Journal of Cardiovascular Pharmacology 8(3): 554-558
Maayan, M.L.; Sellitto, R.V.; Volpert, E.M. 1986: Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release. Endocrinology 118(2): 632-636
Racagni, G.; Oliverio, A.; Bruno, F.; Maggi, A.; Cattabeni, F. 1977: Dopamine and acetylcholine interactions in brain structures of mouse strains with different sensitivities to morphine. Advances in Biochemical Psychopharmacology 16: 565-570
Malais, P.; Waltregny, A.; Maula, A.; Dresse, A. 1990: Dopamine and acetylcholine release in thalamus of non-parkinsonian and parkinsonian subjects. Acta Neurologica Belgica 90(4): 200-206
Dun, N.J.; Kaibara, K.; Karczmar, A.G. 1977: Dopamine and adenosine 3',5'-monophosphate responses of single mammalian sympathetic neurons. Science 197(4305): 778-780
Allain, H. 1988: Dopamine and aging: physiopathological basis of the neurobiological deficit in subjects over 50 years of age. La Revue du praticien 38(25 Suppl): 25-28
O'Connor, I.; Cowburn, R.F.; Hardy, J.A.; Fowler, C.J. 1988: Dopamine and apomorphine do not modulate the uptake of [3H]D-aspartate in the rat striatum in-vitro. Journal of Pharmacy and Pharmacology 40(4): 307-308
Thompson, W.L. 1977: Dopamine and blood flow. American Heart Journal 93(2): 266
De Mello, F.G. 1978: Dopamine and cyclic nucleotides in the retina of the developing chick embryo (proceedings). Anais da Academia Brasileira de Ciencias 50(2): 259
Lechin, F.; van der Dus, B. 1979: Dopamine and distal colon motility. Digestive Diseases and Sciences 24(1): 86-87
Rée, G.H. 1978: Link between hepatoma and hepatitis B. British Medical Journal 2(6145): 1166
Pedersen, C.B.; Strøm, J.; Angelo, H.R.; Munksgaard, A.; Høgskilde, S.; Bredgaard Sørensen, M. 1991: Dopamine and dobutamine reduce myocardial d-propoxyphene content in experimentally intoxicated rats. Human and Experimental Toxicology 10(2): 109-112
Crockett, M.; Tappero, E. 1989: Dopamine and dobutamine: neonatal indications and implications. Neonatal Network: Nn 7(5): 13-20
Van Zwieten, P.A. 1990: Dopamine and dopaminergic drugs as therapeutic agents in heart failure. Nederlands Tijdschrift Voor Geneeskunde 134(47): 2281-2284
Aylmer, C.G.; Steinberg, H.; Webster, R.A. 1975: Dopamine and drug-induced hyperactivity in rats. British Journal of Pharmacology 55(2): 293P-294P
Churchill, L.; Austin, M.C.; Kalivas, P.W. 1992: Dopamine and endogenous opioid regulation of picrotoxin-induced locomotion in the ventral pallidum after dopamine depletion in the nucleus accumbens. Psychopharmacology 108(1-2): 141-146
Llorens-Cortes, C.; Martres, M.P.; Van Amsterdam, Y.; Giros, B.; Gros, C.; Pollard, H.; Schwartz, J.C. 1989: Dopamine and enkephalins. Effects of dopaminergic agents on the levels of striatal tyrosyl-glycyl-glycine. L'Encephale 15(Special Issue): 105-109
Glavin, G.B. 1991: Dopamine and gastroprotection. the brain-gut axis. Digestive Diseases and Sciences 36(12): 1670-1672
Berretta, S.; Robertson, H.A.; Graybiel, A.M. 1992: Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. Journal of Neurophysiology 68(3): 767-777
Sweatman, P.; Jell, R.M. 1977: Dopamine and histamine sensitivity of rostral hypothalamic neurones in the cat: possible involvement in thermoregulation. Brain Research 127(1): 173-178
Bird, E.D.; Crow, T.J.; Iversen, L.L.; Longden, A.; Mackay, A.V.; Riley, G.J.; Spokes, E.G. 1979: Dopamine and homovanillic acid concentrations in the post-mortem brain in schizophrenia. Journal of Physiology 293: 36P-37P
Sandyk, R. 1988: Dopamine and insulin interact to modulate in vitro glucose transport in rat adipocytes. International Journal of Neuroscience 43(1-2): 9-14
Nitenberg, G.; Lhoste, F.; Harari, A. 1976: Dopamine and isoprenaline: pharmacology and therapeutic indications. La Revue du Praticien 26(49): 3475-3488
Cohen, A.I.; Blazynski, C. 1990: Dopamine and its agonists reduce a light-sensitive pool of cyclic AMP in mouse photoreceptors. Visual Neuroscience 4(1): 43-52
Jork, R.; Lössner, B.; Matthies, H. 1979: Dopamine and macromolecule synthesis in rat hippocampus. Pharmacology Biochemistry and Behavior 11(2): 247-249
Pfannenstiel, H.D.; Schlawny, A.; Hamann, T.; Müller, M.; Rhode, B.; Spiehl, D. 1990: Dopamine and male/female differentiation in a hermaphroditic polychaete (Ophryotrocha puerilis). Progress in Clinical and Biological Research 342: 219-225
Rudolf, G.; Vivien-Roels, B.; Pévet, P.; Kempf, E.; Wioland, N. 1992: Dopamine and melatonin interactions in the intact chicken eye. Electrooculographic and biochemical study. Brain Research 584(1-2): 64-70
Mohr, E.; Fabbrini, G.; Williams, J.; Schlegel, J.; Cox, C.; Fedio, P.; Chase, T.N. 1989: Dopamine and memory function in Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society 4(2): 113-120
Bertorello, A.M. 1992: Dopamine and natriuresis. Molecular aspects and physiopathological significance. Medicina 52(1): 72-78
Goldberg, L.I. 1988: Dopamine and new dopamine analogs: receptors and clinical applications. Journal of Clinical Anesthesia 1(1): 66-74
Lindvall, O.; Stenevi, U. 1978: Dopamine and noradrenaline neurons projecting to the septal area in the rat. Cell and Tissue Research 190(3): 383-407
Van Kammen, D.P.; Kelley, M. 1991: Dopamine and norepinephrine activity in schizophrenia. An integrative perspective. Schizophrenia Research 4(2): 173-191
Shibata, O.; Yorozuya, Y.; Nagatani, A.; Shimada, M.; Haseba, S.; Gotoh, Y.; Honda, Y. 1986: Dopamine and norepinephrine concentrations in the human digestive tract following exogenous dopamine administration. Masui. Japanese Journal of Anesthesiology 35(12): 1830-1835
Pequignot, J.M.; Cottet-Emard, J.M.; Dalmaz, Y.; Peyrin, L. 1987: Dopamine and norepinephrine dynamics in rat carotid body during long-term hypoxia. Journal of the Autonomic Nervous System 21(1): 9-14
Oke, A.; Keller, R.; Adams, R.N. 1978: Dopamine and norepinephrine enhancement in discrete rat brain regions following neonatal 6-hydroxydopamine treatment. Brain Research 148(1): 245-250
Koslow, S.H. 1977: Dopamine and other catecholamine-containing SIF cells. Advances in Biochemical Psychopharmacology 16: 553-556
Thompson, W.L. 1979: Dopamine and other vaso-active agents in shock (edited summary). Scottish Medical Journal 24(1): 89-93
Kirsch, M.; Wagner, H.J.; Djamgoz, M.B. 1991: Dopamine and plasticity of horizontal cell function in the teleost retina: regulation of a spectral mechanism through D1-receptors. Vision Research 31(3): 401-412
Polansky, D.; Eberhard, N.; McGrath, R. 1987: Dopamine and polyuria. Annals of Internal Medicine 107(6): 941
Duke, G.J.; Bersten, A.D. 1992: Dopamine and renal salvage in the critically ill patient. Anaesthesia and Intensive Care 20(3): 277-287
Myers, W.D.; Ng, K.T.; Singer, G.; Smythe, G.A.; Duncan, M.W. 1985: Dopamine and salsolinol levels in rat hypothalami and striatum after schedule-induced self-injection (SISI) of ethanol and acetaldehyde. Brain Research 358(1-2): 122-128
Reiner, N.E.; Thompson, W.L. 1979: Dopamine and saralasin antagonism of renal vasoconstriction and oliguria caused by amphotericin B in dogs. Journal of Infectious Diseases 140(4): 564-575
Broderick, P.A.; Gibson, G.E. 1989: Dopamine and serotonin in rat striatum during in vivo hypoxic-hypoxia. Metabolic Brain Disease 4(2): 143-153
Cohen, D.J.; Caparulo, B.K.; Shaywitz, B.A.; Bowers, M.B. 1977: Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid. Archives of General Psychiatry 34(5): 545-550
Kempf, E.; Fuhrmann, G.; Thiriet, G.; Ebel, A. 1985: Dopamine and serotonin metabolism in striatum and in the septohippocampal pathway of the Snell dwarf mouse. Neurochemical Research 10(7): 969-981
Hamon, M. 1989: Dopamine and serotonin. Involvement in the central effects of psychotropic agents. L'Encephale 15(Special Issue): 119-125
Whishaw, I.Q.; Castañeda, E.; Gorny, B.P. 1992: Dopamine and skilled limb use in the rat: more severe bilateral impairments follow substantia nigra than sensorimotor cortex 6-hydroxydopamine injection. Behavioural Brain Research 47(1): 89-92
Ray, K.P.; Gomm, J.J.; Law, G.J.; Sigournay, C.; Wallis, M. 1986: Dopamine and somatostatin inhibit forskolin-stimulated prolactin and growth hormone secretion but not stimulated cyclic AMP levels in sheep anterior pituitary cell cultures. Molecular and Cellular Endocrinology 45(2-3): 175-182
Moser, A.; Reavill, C.; Liebetrau, A.; Jenner, P.; Marsden, C.D.; Cramer, H. 1987: Dopamine and somatostatin modulated adenylate cyclase activity in the rat caudate-putamen following unilateral cortical ablation. Experimental Brain Research 68(2): 406-410
Schmauss, C.; Emrich, H.M. 1985: Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia. with special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia. Biological Psychiatry 20(11): 1211-1231
Ferri, S.; Reina, R.; Santagostino, A. 1977: Dopamine and the depressant action of morphine on stimulated guinea-pig ileum. British Journal of Pharmacology 59(1): 25-28
Adam, W.R.; Goland, G. 1979: Dopamine and the enhanced renal response to aldosterone in the rat on a high potassium diet. Clinical and Experimental Pharmacology and Physiology 6(6): 631-635
Everett, G.M. 1977: Dopamine and the hyperkinetic child. Advances in Biochemical Psychopharmacology 16: 681-682
Smit, A.J. 1989: Dopamine and the kidney. Netherlands Journal of Medicine 34(1-2): 47-58
Thal, L.; Mishra, R.K.; Gardner, E.L.; Horowitz, S.G.; Varmuza, S.; Makman, M.H. 1979: Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes. Brain Research 170(2): 381-386
Ulrich, U.; Nehmzow, M.; Krause, B.; Göretzlehner, G.; Döcke, F. 1990: Dopamine antagonists in anovulation?. Zentralblatt für Gynakologie 112(20): 1295-1298
Zolman, J.F.; McDougall, S.A. 1990: Dopamine antagonists produce an age-dependent increase in the responding of the young chick. Developmental Psychobiology 23(2): 141-155
Friedhoff, A.J. 1988: Dopamine as a mediator of a central stabilizing system. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 1(3): 189-191
Skirboll, L.R.; Grace, A.A.; Bunney, B.S. 1979: Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. Science 206(4414): 80-82
Jaen, J.C.; Wise, L.D.; Heffner, T.G.; Pugsley, T.A.; Meltzer, L.T. 1988: Dopamine autoreceptor agonists as potential antipsychotics. 1. (Aminoalkoxy)anilines. Journal of Medicinal Chemistry 31(8): 1621-1625
Jaen, J.C.; Wise, L.D.; Heffner, T.G.; Pugsley, T.A.; Meltzer, L.T. 1991: Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones. Journal of Medicinal Chemistry 34(1): 248-256
Caprathe, B.W.; Jaen, J.C.; Wise, L.D.; Heffner, T.G.; Pugsley, T.A.; Meltzer, L.T.; Parvez, M. 1991: Dopamine autoreceptor agonists as potential antipsychotics. 3.6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine. Journal of Medicinal Chemistry 34(9): 2736-2746
Wilmot, C.A.; Fico, T.A.; Vanderwende, C.; Spoerlein, M.T. 1989: Dopamine autoreceptor agonists attenuate spontaneous motor activity but not spontaneous fighting in individually-housed mice. Pharmacology Biochemistry and Behavior 33(2): 387-391
Altar, C.A.; Boyar, W.C.; Wood, P.L. 1987: Dopamine autoreceptor agonists including CGS 15855A decrease dopamine release and metabolism in mouse brain. European Journal of Pharmacology 134(3): 303-311
Schneider, C.S.; Mierau, J. 1987: Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analogue of apomorphine. Journal of Medicinal Chemistry 30(3): 494-498
Svensson, K.; Alföldi, P.; Hajós, M.; Rubicsek, G.; Johansson, A.M.; Carlsson, A.; Obál, F. 1987: Dopamine autoreceptor antagonists: effects on sleep-wake activity in the rat. Pharmacology Biochemistry and Behavior 26(1): 123-129
Chiodo, L.A. 1992: Dopamine autoreceptor signal transduction in the DA cell body: a "current view". Neurochemistry International 20 Suppl: 81s-84s
Miras Portugal, M.T.; Aunis, D.; Mandel, P.; Warter, J.M.; Coquillat, G.; Collard, M.; Rohmer, F. 1976: Dopamine beta hydroxylase. Value and limits of its study in neurology. Revue Neurologique (Paris) 132(6): 383-389
Markiewicz, P. 1989: Dopamine beta-hydroxylase activity after subarachnoid hemorrhage. Polski Tygodnik Lekarski 44(5): 109-111
Wyatt, R.J.; Schwartz, M.A.; Erdelyi, E.; Barchas, J.D. 1975: Dopamine beta-hydroxylase activity in brains of chronic schizophrenic patients. Science 187(4174): 368-370
Suzuki, H.; Sakuragawa, N. 1992: Dopamine beta-hydroxylase activity in cerebrospinal fluid of hydrocephalic patients. No to Hattatsu 24(3): 234-237
Park, D.H.; Kang, U.J.; Moskowitz, C.B.; Burke, R.E.; Joh, T.H.; Fahn, S. 1990: Dopamine beta-hydroxylase activity in cerebrospinal fluid of idiopathic torsion dystonia. Neurology 40(10): 1626-1628
Sodolski, W.; Stelmasiak, T.; Hanzlik, J.; Mieczkowska, J.; Tyburczyk, W. 1979: Dopamine beta-hydroxylase activity in diabetes mellitus. Endokrynologia Polska 30(2): 189-196
Kato, T.; Nagatsu, T.; Hashimoto, Y.; Numata-Sudo, Y.; Yamori, Y.; Okamoto, K. 1978: Dopamine beta-hydroxylase activity in stroke-prone spontaneously hypertensive rats. Japanese Heart Journal 19(4): 641
Behrens, W.A.; Depocas, F. 1977: Dopamine beta-hydroxylase and cytochrome oxidase activities in brown adipose tissue of newborn rats following sympathectomy with 6-hydroxydopamine. Canadian Journal of Physiology and Pharmacology 55(3): 695-699
Lawton, W.J.; Fitz, A.; Grant, C.; Witte, D.L. 1979: Dopamine beta-hydroxylase and plasma renin activity in patients with low-, normal-, and high-renin essential hypertension. Circulation 59(5): 1063-1069
Kanter, W.; Wooten, G.F.; Eldridge, R. 1976: Dopamine beta-hydroxylase and the torsion dystonias. Advances in Neurology 14: 303-305
Nagatsu, T.; Kato, T.; Numata, Y.; Ikuta, K.; Kuzuya, H. 1975: Dopamine beta-hydroxylase and tyrosine hydroxylase activities in spontaneously hypertensive rats after NaCl administration. Experientia 31(7): 767-768
Robertson, D.; Haile, V.; Perry, S.E.; Robertson, R.M.; Phillips, J.A.; Biaggioni, I. 1991: Dopamine beta-hydroxylase deficiency. a genetic disorder of cardiovascular regulation. Hypertension 18(1): 1-8
Klein, R.L.; Thureson-Klein, A.K.; Yen, S.H.; Baggett, J.M.; Gasparis, M.S.; Kirksey, D.F. 1979: Dopamine beta-hydroxylase distribution in density gradients: physiological and artefactual implications. Journal of Neurobiology 10(3): 291-307
Van der Meer, R.A.; Jongejan, J.A.; Duine, J.A. 1988: Dopamine beta-hydroxylase from bovine adrenal medulla contains covalently-bound pyrroloquinoline quinone. Febs Letters 231(2): 303-307
Schuback, D.; Kramer, P.; Ozelius, L.; Holmgren, G.; Forsgren, L.; Kyllerman, M.; Wahlström, J.; Craft, C.M.; Nygaard, T.; Brin, M. 1991: Dopamine beta-hydroxylase gene excluded in four subtypes of hereditary dystonia. Human Genetics 87(3): 311-316
Wocial, B.; Pawlowski, W.; Minarikowa, E.; Januszewicz, W. 1989: Dopamine beta-hydroxylase in disorders of blood pressure regulation. Kardiologia Polska 32 Suppl. 1: 79-86
Sanchez-Martín, M.; García, A.G. 1977: Dopamine beta-hydroxylase in human synovial fluid. Experientia 33(5): 650-652
Behrens, W.A.; Depocas, F. 1975: Dopamine beta-hydroxylase in rat serum and lymph: changes with age and effect of cold exposure. Canadian Journal of Physiology and Pharmacology 53(6): 1080-1088
Arnold, J.; Choo, J.J.; Little, R.A.; Rothwell, N.J. 1990: Dopamine beta-hydroxylase inhibition reveals a selective influence of endotoxin on catecholamine content of rat tissues. Circulatory Shock 31(4): 387-394
Mathias, C.J.; Smith, A.D.; Frankel, H.L.; Spalding, J.M. 1976: Dopamine beta-hydroxylase release during hypertension from sympathetic nervous overactivity in man. Cardiovascular Research 10(2): 176-181
Chen, I.L.; Hansen, J.T.; Yates, R.D. 1985: Dopamine beta-hydroxylase-like immunoreactivity in the rat and cat carotid body: a light and electron microscopic study. Journal of Neurocytology 14(1): 131-144
Joh, T.H.; Hwang, O. 1987: Dopamine beta-hydroxylase: biochemistry and molecular biology. Annals of the new York Academy of Sciences 493: 342-350
Kowalczuk, K.; Jesionek, D.; Nowosadzka, E.; Borkowska, I. 1988: Dopamine beta-monooxygenase activity in the brain and adrenal glands of pt rabbits. Neuropatologia Polska 26(2): 225-232
Ljones, T. 1987: Dopamine beta-monooxygenase from bovine adrenal medulla. Methods in Enzymology 142: 596-602
Frigon, R.P. 1987: Dopamine beta-monooxygenase from human plasma. Methods in Enzymology 142: 603-607
Ljones, T.; Flatmark, T.; Skotland, T.; Petersson, L.; Bäckström, D.; Ehrenberg, A. 1978: Dopamine beta-monooxygenase: electron paramagnetic resonance and oxidation--reduction properties of the enzyme-bound copper. Febs Letters 92(1): 81-84
Skotland, T.; Ljones, T.; Flatmark, T. 1978: Dopamine beta-monooxygenase: reduced enzyme needs additional reductant for completion of the catalytic cycle. Biochemical and Biophysical Research Communications 84(1): 83-88
Hitri, A.; Weiner, W.J.; Borison, R.L.; Diamond, B.I.; Nausieda, P.A.; Klawans, H.L. 1978: Dopamine binding following prolonged haloperidol pretreatment. Annals of Neurology 3(2): 134-140
Coruzzi, P.; Musiari, L.; Biggi, A.; Ravanetti, C.; Novarini, A. 1987: Dopamine blockade abolishes the exaggerated natriuresis of essential hypertension. Journal of Hypertension 5(5): 587-591
Austin, L.S.; Lydiard, R.B.; Ballenger, J.C.; Cohen, B.M.; Laraia, M.T.; Zealberg, J.J.; Fossey, M.D.; Ellinwood, E.H. 1991: Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder. Biological Psychiatry 30(3): 225-232
Melamed, E.; Rosenthal, J.; Cohen, O.; Globus, M.; Uzzan, A. 1985: Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP. European Journal of Pharmacology 116(1-2): 179-181
Raiteri, M.; Cerrito, F.; Cervoni, A.M.; Levi, G. 1979: Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. Journal of Pharmacology and Experimental Therapeutics 208(2): 195-202
Negishi, K.; Kato, S.; Teranishi, T. 1988: Dopamine cells and rod bipolar cells contain protein kinase C-like immunoreactivity in some vertebrate retinas. Neuroscience Letters 94(3): 247-252
Bazhenova, S.I.; Saul'skaia, N.B. 1979: Dopamine concentration in the nigrostriatal system during electrical stimulation of the head of the caudate nucleus. Fiziologicheskii Zhurnal SSSR Imeni I. M. Sechenova 65(4): 521-526
Da Prada, M. 1977: Dopamine content and synthesis in retina and n. accumbens septi: pharmacological and light-induced modifications. Advances in Biochemical Psychopharmacology 16: 311-319
García-Robles, R.; Ruilope, L.; Tovar, J.; de Villa, L.F.; Miranda, B.; Prieto, C.; Parada, J.; Sancho, J.; Rodicio, J.L. 1986: Dopamine control of aldosterone secretion in end-stage renal failure. Revista Espanola de Fisiologia 42(2): 257-263
Turski, W.A.; Cavalheiro, E.A.; Ikonomidou, C.; Bortolotto, Z.A.; Klockgether, T.; Turski, L. 1990: Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures. Synapse 5(2): 113-119
Hoehn, M.M.; Crowley, T.J.; Rutledge, C.O. 1976: Dopamine correlates of neurological and psychological status in untreated Parkinsonism. Journal of Neurology Neurosurgery and Psychiatry 39(10): 941-951
Lundberg, J.; Lundberg, D.; Norgren, L.; Werner, O. 1990: Dopamine counteracts hypertension during general anesthesia and hypotension during combined thoracic epidural anesthesia for abdominal aortic surgery. Journal of Cardiothoracic Anesthesia 4(3): 348-353
Mercuri, N.; Bernardi, G.; Calabresi, P.; Cotugno, A.; Levi, G.; Stanzione, P. 1985: Dopamine decreases cell excitability in rat striatal neurons by pre- and postsynaptic mechanisms. Brain Research 358(1-2): 110-121
Tasaka, K.; Miyake, A.; Sakumoto, T.; Aono, T. 1985: Dopamine decreases release of luteinizing hormone releasing hormone from superfused rat mediobasal hypothalamus. Journal of Endocrinological Investigation 8(4): 373-376
Malenka, R.C.; Nicoll, R.A. 1986: Dopamine decreases the calcium-activated afterhyperpolarization in hippocampal CA1 pyramidal cells. Brain Research 379(2): 210-215
Breese, G.R.; Criswell, H.E.; Duncan, G.E.; Mueller, R.A. 1989: Dopamine deficiency in self-injurious behavior. Psychopharmacology Bulletin 25(3): 353-357
Shoshina, L.M.; Grinio, L.P.; Mineeva, M.F. 1990: Dopamine deficiency syndrome in children with a special reaction to treatment with levodopa preparations. Neuroscience and Behavioral Physiology 20(5): 395-400
Shoshina, L.M.; Grinio, L.P.; Mineeva, M.F. 1989: Dopamine deficiency syndrome in children with specific reaction to the treatment with levodopa preparations. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 89(8): 27-32
Ehrlein, H.J. 1988: Dopamine delays gastric emptying and induces retrograde power contractions with enterogastric reflux. Zeitschrift für Gastroenterologie 26(3): 160-165
Bennett, J.P.; Wooten, G.F. 1986: Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease. Annals of Neurology 19(4): 378-383
Esposito, E.; Cervo, L.; Petrillo, P.; Sbacchi, M.; Tavani, A.; Samanin, R. 1987: Dopamine denervation of the nucleus accumbens induces a selective increase in the number of delta-opioid binding sites. Brain Research 436(1): 25-29
Sivam, S.P. 1991: Dopamine dependent decrease in enkephalin and substance P levels in basal ganglia regions of postmortem parkinsonian brains. Neuropeptides 18(4): 201-207
Bertorelli, R.; Zambelli, M.; Di Chiara, G.; Consolo, S. 1992: Dopamine depletion preferentially impairs D1- over D2-receptor regulation of striatal in vivo acetylcholine release. Journal of Neurochemistry 59(1): 353-357
Churchill, L.; Kalivas, P.W. 1992: Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation. Synapse 11(1): 47-57
Clemens, J.A.; Phebus, L.A. 1988: Dopamine depletion protects striatal neurons from ischemia-induced cell death. Life Sciences 42(6): 707-713
Kant, G.J.; Lenox, R.H.; Meyerhoff, J.L. 1979: Dopamine diffusion after microwave fixation at 986 MHz. Neurochemical Research 4(4): 529-534
Elliott, R.K. 1978: Dopamine dosage calculations. American Journal of Hospital Pharmacy 35(1): 20
Prudnikov, I.M.; Osipenko, O.N.; Kastrikina, T.F.; Tsyvkin, V.N. 1992: Dopamine effect on ionic conduction and adenyl cyclase activity in the central nervous system of the pond snail. Neirofiziologiia 24(4): 437-451
Connell, J.M.; Davies, D.L.; Fraser, R.; Kenyon, C.J. 1986: Dopamine effects on 11-deoxycorticosterone concentrations in patients with Cushing's syndrome and in vitro. Clinical Endocrinology 25(4): 427-433
Brückner, J.B.; Hess, W.; Schmidt, D.; Schneider, E.; Schweichel, E. 1977: Dopamine effects on circulation and myocardial oxygen supply. Proceedings of the Royal Society of Medicine 70(Suppl 2): 43-47
Oku, T.; Koike, R.; Minohara, S.; Satoh, H.; Kimura, H.; Sasaki, S.; Takeuchi, A. 1987: Dopamine effects on plasma catecholamine levels following aorto-coronary bypass graft. Nihon Geka Gakkai Zasshi 88(3): 361
Snyder, G.L.; Keller, R.W.; Zigmond, M.J. 1990: Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. Journal of Pharmacology and Experimental Therapeutics 253(2): 867-876
Martin, G.E.; Myers, R.D. 1976: Dopamine efflux from the brain stem of the rat during feeding, drinking and lever-pressing for food. Pharmacology Biochemistry and Behavior 4(5): 551-560
Napier, T.C.; Simson, P.E.; Givens, B.S. 1991: Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus. Journal of Pharmacology and Experimental Therapeutics 258(1): 249-262
Login, I.S.; Pancrazio, J.J.; Kim, Y.I. 1990: Dopamine enhances a voltage-dependent transient K+ current in the MMQ cell, a clonal pituitary line expressing functional D2 dopamine receptors. Brain Research 506(2): 331-334
Yang, C.R.; Mogenson, G.J. 1986: Dopamine enhances terminal excitability of hippocampal-accumbens neurons via D2 receptor: role of dopamine in presynaptic inhibition. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 6(8): 2470-2478
Sawaguchi, T.; Matsumura, M.; Kubota, K. 1988: Dopamine enhances the neuronal activity of spatial short-term memory task in the primate prefrontal cortex. Neuroscience Research 5(5): 465-473
Isaac, J.; Berndt, T.J.; Chinnow, S.L.; Tyce, G.M.; Dousa, T.P.; Knox, F.G. 1992: Dopamine enhances the phosphaturic response to parathyroid hormone in phosphate-deprived rats. Journal of the American Society of Nephrology: Jasn 2(9): 1423-1429
Crowley, T.J.; Hoehn, M.M.; Rutledge, C.O.; Stallings, M.A.; Heaton, R.K.; Sundell, S.; Stilson, D. 1978: Dopamine excretion and vulnerability to drug-induced Parkinsonism. Schizophrenic patients. Archives of General Psychiatry 35(1): 97-104
Serrano, P.A.; Chavez-Lara, B.; Sanchez-Torres, G. 1978: Dopamine excretion in benign pheochromocytoma. Biomedicine / 29(7): 229-231
Hantraye, P.; Brownell, A.L.; Elmaleh, D.; Spealman, R.D.; Wüllner, U.; Brownell, G.L.; Madras, B.K.; Isacson, O. 1992: Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism. Neuroreport 3(3): 265-268
McRae, A.; Hjorth, S.; Dahlström, A.; Dillon, L.; Mason, D.; Tice, T. 1992: Dopamine fiber growth induction by implantation of synthetic dopamine-containing microspheres in rats with experimental hemi-parkinsonism. Molecular and Chemical Neuropathology 16(1-2): 123-141
Anonymous 1975: Dopamine for treatment of shock. Medical Letter on Drugs and Therapeutics 17(4): 13-14
Bagchi, S.P.; Smith, T.M. 1977: Dopamine formation from phenylalanine: independent existence in caudate nucleus synaptosomes. Journal of Neural Transmission 41(2-3): 101-107
Jones, M.W.; Kilpatrick, I.C.; Phillipson, O.T. 1988: Dopamine function in the prefrontal cortex of the rat is sensitive to a reduction of tonic GABA-mediated inhibition in the thalamic mediodorsal nucleus. Experimental Brain Research 69(3): 623-634
Law, G.J.; Pachter, J.A.; Dannies, P.S. 1988: Dopamine has no effect on thyrotropin-releasing hormone mobilization of calcium from intracellular stores in rat anterior pituitary cells. Molecular Endocrinology 2(10): 966-972
Marshall, J.F.; O'Dell, S.J.; Navarrete, R.; Rosenstein, A.J. 1990: Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum. Neuroscience 37(1): 11-21
Agnoli, G.C.; Cacciari, M.; Garutti, C.; Lenzi, P. 1979: Dopamine hydro-natriuresis. - I) Intrarenal mechanism responsible for this phenomenon. Bollettino della Societa Italiana di Biologia Sperimentale 55(4): 297-303
Agnoli, G.C.; Cacciari, M.; Garutti, C.; Lenzi, P. 1979: Dopamine hydro-natriuresis. - II) Interactions of dopamine and expansion of extracellular liquid volume. Bollettino della Societa Italiana di Biologia Sperimentale 55(4): 304-310
Wright, J.S.; Newman, D.C.; Torda, T.A. 1977: Dopamine hydrochloride (Intropin) and open-heart surgery: results of a clinical trial. Medical Journal of Australia 1(18): 651-653
Linhardt, G.; Champion, H.R.; Gill, W. 1977: Dopamine hydrochloride in severe hemorrhagic shock. Maryland State Medical Journal 26(5): 60-65
Allen, R.M. 1977: Dopamine hypersensitivity and tardive dyskinesia. American Journal of Psychiatry 134(10): 1154-1155
Yamashita, I. 1977: Dopamine hypothesis of schizophrenia. Hokkaido Journal of Medical Science 52(1): 74-75
Anonymous 1977: Dopamine in cardiac failure and shock. British Medical Journal 2(6102): 1563-1564
Schröder, R. 1979: Dopamine in cardiogenic shock. Deutsche Medizinische Wochenschrift 104(40): 1400
Biaggioni, I.; Hollister, A.S.; Robertson, D. 1987: Dopamine in dopamine-beta-hydroxylase deficiency. New England Journal of Medicine 317(22): 1415-1416
Chávez Lara, B.; Serrano, P.A.; Sánchez Torres, G.; Chávez Domínguez, R. 1975: Dopamine in essential arterial hypertension: excretion of its metabolite homovanillic acid. Archivos del Instituto de Cardiologia de Mexico 45(1): 77-81
Ben-Jonathan, N.; Oliver, C.; Weiner, H.J.; Mical, R.S.; Porter, J.C. 1977: Dopamine in hypophysial portal plasma of the rat during the estrous cycle and throughout pregnancy. Endocrinology 100(2): 452-458
Morena Hinojosas, V.; Elorza Fernández, M.D.; Beceiro Mosquera, J.; Burgueros Valero, M.; García-Alix Pérez, A.; Pérez Rodríguez, J.; Quero Jiménez, J. 1988: Dopamine in hypotensive neonates. Study of 31 cases. Anales Espanoles de Pediatria 29(5): 363-368
Silverstone, T. 1985: Dopamine in manic depressive illness. a pharmacological synthesis. Journal of Affective Disorders 8(3): 225-231
Minciu, E.; Bosneag, M. 1985: Dopamine in neurology and psychiatry--unusual clinical aspects. Revista de Medicina Interna Neurologie Psihiatrie Neurochirurgie Dermato-Venerologie. Neurologie Psihiatrie Neurochirurgie 30(4): 255-260
Daenen, W.; de Leval, M.; Stark, J. 1977: Dopamine in open-heart surgery for congenital heart disease. Proceedings of the Royal Society of Medicine 70(Suppl 2): 48-50
Ho, I.K.; Hoskins, B. 1990: Dopamine in organophosphate-induced neurotoxicity. Journal of Toxicological Sciences 15(Suppl): 159-161
Azzarelli, B.; Felten, S.; Muller, J.; Miyamoto, R.; Purvin, V. 1988: Dopamine in paragangliomas of the glomus jugulare. Laryngoscope 98(5): 573-578
Kikis, D.; Esser, H.; Trübestein, G. 1977: Dopamine in patients with cardiogenic shock. Medizinische Klinik 72(28-29): 1212-1217
Hagege, J.; Wahbe, F.; Wiemeyer, A.; Richet, G. 1985: Dopamine in rat kidney slices--its production and its histofluorescent localization. Contributions to Nephrology 49: 140-144
Heritch, A.J. 1992: Dopamine in schizophrenia. American Journal of Psychiatry 149(11): 1620-1621
Brose, N.; O'Neill, R.D.; Boutelle, M.G.; Fillenz, M. 1988: Dopamine in the basal ganglia and benzodiazepine-induced sedation. Neuropharmacology 27(6): 589-595
Sirenko, I.N. 1989: Dopamine in the combined treatment of heart failure in a patient with Abramov-Fiedler myocarditis. Vrachebnoe Delo 4: 41-43
Chiueh, C.C. 1988: Dopamine in the extrapyramidal motor function. a study based upon the MPTP-induced primate model of parkinsonism. Annals of the new York Academy of Sciences 515: 226-238
Wilson, J.R. 1977: Dopamine in the hepatorenal syndrome. JAMA 238(25): 2719-2720
Ruwe, W.D.; Myers, R.D. 1978: Dopamine in the hypothalamus of the cat: pharmacological characterization and push-pull perfusion analysis of sites mediating hypothermia. Pharmacology Biochemistry and Behavior 9(1): 65-80
Unger, T.; Ganten, D.; Lang, R.E. 1985: Dopamine in the kidney: a further natriuretic hormone?. Fortschritte der Medizin 103(14): 357-360
Thompson, W.L. 1977: Dopamine in the management of shock. Proceedings of the Royal Society of Medicine 70(Suppl 2): 25-35
Pettit, H.O.; Justice, J.B. 1989: Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacology Biochemistry and Behavior 34(4): 899-904
Iumatov, T.D.; Isakov, A.V.; Potin, V.V.; Svechnikova, F.A. 1986: Dopamine in the pathogenesis of normogonadotropic amenorrhea. Problemy Endokrinologii 32(4): 32-36
Napier, T.C.; Potter, P.E. 1989: Dopamine in the rat ventral pallidum/substantia innominata: biochemical and electrophysiological studies. Neuropharmacology 28(7): 757-760
Zimin, I.V.; Kuznetsova, G.V.; Evdokimov, V.V. 1979: Dopamine in the treatment of coronary shock. Kardiologiia 19(5): 34-39
Miller, A.J. 1977: Dopamine in the treatment of heart failure. Proceedings of the Royal Society of Medicine 70(Suppl 2): 16-24
Farley, I.J.; Price, K.S.; Hornykiewicz, O. 1977: Dopamine in thelimbic regions of the human brain: normal and abnormal. Advances in Biochemical Psychopharmacology 16: 57-64
Polacco, V.; Tambuscio, B.; Suma, V.; Scivoli, L.; Rondinelli, M. 1976: Dopamine in threatened premature labor and in placental insufficiency. Preliminary observations. Rivista Italiana di Ginecologia 57(2): 133-140
Ramdohr, B.; Biamino, G.; Schŭren, K.P.; Schrŏder, R. 1975: Dopamine in treatment of acute severe heart insufficiency. Die Medizinische Welt 26(12): 540-547
Fogari, R.; Marchesi, E.; Ranieri, M.G.; Cebrelli, C. 1977: Dopamine in urine and natriuresis after water loading. Bollettino della Societa Italiana di Biologia Sperimentale 53(3): 129-132
Abraini, J.H.; Rostain, J.C. 1991: Dopamine increase in the nucleus accumbens of rats exposed to high pressure. Neuroreport 2(5): 233-235
Kester, R.R.; Mooppan, U.M.; Alver, J.E.; Gintautas, J.; Abadir, A.R.; Kim, H. 1989: Dopamine induced contraction of human prostate in vitro. Proceedings of the Western Pharmacology Society 32: 85-90
Nogler, R.; Keibel, M. 1978: Dopamine induced gangrene. Journal of the Maine Medical Association 69(2): 47
Goldberg, L.I.; Toda, N. 1975: Dopamine induced relaxation of isolated canine renal, mesenteric, and femoral arteries contracted with prostaglandin F2-alpha. Circulation Research 36(6 Suppl 1: 97-102
Chapman, B.J.; Horn, N.M.; Robertson, M.J. 1978: Dopamine induced vasodilatation in the rat kidney. Journal of Physiology 275: 24P-25P
Keeling, A.B.; Schmidt, P. 1987: Dopamine influence on whole-blood glucose reagent strips. Diabetes Care 10(4): 532
Besses, G.S.; Burrow, G.N.; Spaulding, S.W.; Donabedian, R.K. 1975: Dopamine infusion acutely inhibits the TSH and prolactin response to TRH. Journal of Clinical Endocrinology and Metabolism 41(5): 985-988
Ratge, D.; Steegmüller, U.; Mikus, G.; Kohse, K.P.; Wisser, H. 1990: Dopamine infusion in healthy subjects and critically ill patients. Clinical and Experimental Pharmacology and Physiology 17(5): 361-369
Lenz, K.; Hörtnagl, H.; Unger, H.; Druml, W.; Laggner, A.; Grimm, G.; Schneeweisz, B. 1990: Dopamine infusion in patients with hepatic encephalopathy: plasma levels and haemodynamic changes. Hepato-Gastroenterology 37(Suppl 2): 85-89
Ogoshi, K.; Kondo, Y.; Hara, S.; Iwata, K.; Mitomi, T. 1989: Dopamine infusion test as a gastric secretion test. Nihon Geka Gakkai Zasshi 90(1): 44-48
Aperia, A.C. 1988: Dopamine inhibition of NaKATPase activity in proximal convoluted tubule cells. Progress in Clinical and Biological Research 273: 427-434
Borgundvaag, B.; George, S.R. 1985: Dopamine inhibition of anterior pituitary adenylate cyclase is mediated through the high-affinity state of the D2 receptor. Life Sciences 37(4): 379-386
Omeljaniuk, R.J.; Tonon, M.C.; Peter, R.E. 1989: Dopamine inhibition of gonadotropin and alpha-melanocyte-stimulating hormone release in vitro from the pituitary of the goldfish (Carassius auratus). General and Comparative Endocrinology 74(3): 451-467
Memo, M.; Carboni, E.; Trabucchi, M.; Carruba, M.O.; Spano, P.F. 1985: Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells. Brain Research 347(2): 253-257
Fitzpatrick, S.C.; McKenna, T.J. 1989: Dopamine inhibition of potassium-stimulated aldosterone biosynthesis in bovine adrenal zona glomerulosa cells. Journal of Steroid Biochemistry 32(5): 715-718
Woolf, P.D.; Lantigua, R.; Lee, L.A. 1979: Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man. Journal of Clinical Endocrinology and Metabolism 49(3): 326-330
Takemoto, F.; Cohen, H.T.; Satoh, T.; Katz, A.I. 1992: Dopamine inhibits Na/K-ATPase in single tubules and cultured cells from distal nephron. Pflugers Archiv: European Journal of Physiology 421(4): 302-306
Von Euler, G.; Liu, Y. 1992: Dopamine inhibits [3H]MK-801 binding in membrane preparations from rat cerebral cortex and caudate-putamen. Acta Physiologica Scandinavica 146(4): 547-548
McKenna, T.J.; Island, D.P.; Nicholson, W.E.; Liddle, G.W. 1979: Dopamine inhibits angiotensin-stimulated aldosterone biosynthesis in bovine adrenal cells. Journal of Clinical Investigation 64(1): 287-291
Kato, S.; Negishi, K.; Teranishi, T. 1985: Dopamine inhibits calcium-independent gamma-[3H]aminobutyric acid release induced by kainate and high K+ in the fish retina. Journal of Neurochemistry 44(3): 893-899
Sato, N.; Wang, X.B.; Greer, M.A. 1991: Dopamine inhibits cell swelling-induced prolactin secretion in MMQ cells by blocking Ca2+ influx. Molecular and Cellular Endocrinology 82(1): 99-106
Morra, M.; Leboulenger, F.; Desrues, L.; Tonon, M.C.; Vaudry, H. 1991: Dopamine inhibits inositol phosphate production, arachidonic acid formation, and corticosteroid release by frog adrenal gland through a pertussis toxin-sensitive G-protein. Endocrinology 128(5): 2625-2632
Enjalbert, A.; Musset, F.; Chénard, C.; Priam, M.; Kordon, C.; Heisler, S. 1988: Dopamine inhibits prolactin secretion stimulated by the calcium channel agonist Bay-K-8644 through a pertussis toxin-sensitive G protein in anterior pituitary cells. Endocrinology 123(1): 406-412
Vermes, I.; Tilders, F.J.; Stoof, J.C. 1985: Dopamine inhibits the release of immunoreactive beta-endorphin from rat hypothalamus in vitro. Brain Research 326(1): 41-46
Mitsuma, T.; Sun, D.H.; Nogimori, T.; Chaya, M.; Ohtake, K.; Hirooka, Y. 1987: Dopamine inhibits thyrotropin-releasing hormone release from rat adrenal gland in vitro. Hormone Research 25(4): 223-227
Lledo, P.M.; Legendre, P.; Israel, J.M.; Vincent, J.D. 1990: Dopamine inhibits two characterized voltage-dependent calcium currents in identified rat lactotroph cells. Endocrinology 127(3): 990-1001
Nussinovitch, I.; Kleinhaus, A.L. 1992: Dopamine inhibits voltage-activated calcium channel currents in rat pars intermedia pituitary cells. Brain Research 574(1-2): 49-55
Scanlon, M.F.; Weightman, D.R.; Shale, D.J.; Mora, B.; Heath, M.; Snow, M.H.; Lewis, M.; Hall, R. 1979: Dopamine is a physiological regulator of thyrotrophin (TSH) secretion in normal man. Clinical Endocrinology 10(1): 7-15
Gibbs, D.M.; Neill, J.D. 1978: Dopamine levels in hypophysial stalk blood in the rat are sufficient to inhibit prolactin secretion in vivo. Endocrinology 102(6): 1895-1900
Mosin, V.I.; Agranovich, N.V.; Gudzovskiĭ, A.G. 1987: Dopamine levels in the gastric and duodenal mucosa, blood and urine in patients with duodenal ulcer. Terapevticheskii Arkhiv 59(2): 18-22
Bernath, S.; Zigmond, M.J. 1989: Dopamine may influence striatal GABA release via three separate mechanisms. Brain Research 476(2): 373-376
Miura, Y.; Ohzeki, T.; Watanabe, T.; Yoshinaga, K. 1992: Dopamine mechanisms in salt-responsive hypertension. Nihon Rinsho. Japanese Journal of Clinical Medicine 50 Suppl: 501-506
Westerling, P.; Lindgren, S.; Höglund, U. 1988: Dopamine mediated behavior and GABA influence. Pharmacology Biochemistry and Behavior 31(3): 593-596
Iuvone, P.M.; Boatright, J.H.; Bloom, M.M. 1987: Dopamine mediates the light-evoked suppression of serotonin N-acetyltransferase activity in retina. Brain Research 418(2): 314-324
Vescovi, A.; Facheris, L.; Zaffaroni, A.; Malanca, G.; Parati, E.A. 1991: Dopamine metabolism alterations in a manganese-treated pheochromocytoma cell line (PC12). Toxicology 67(2): 129-142
Saul'skaia, N.B. 1988: Dopamine metabolism and the GABA level in the structures of the nigrostriatal and mesolimbic systems of the rat brain in experimental pathology of higher nervous activity. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 38(6): 1145-1151
Osborne, N.N.; Priggemeier, E.; Neuhoff, V. 1975: Dopamine metabolism in characterised neurones of Planorbis corneus. Brain Research 90(2): 261-271
Praag, H.M.; Korf, J.; Lakke JPWF; Schut, T. 1975: Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders. Psychological Medicine 5(2): 138-146
Bitler, C.M.; Howard, B.D. 1986: Dopamine metabolism in hypoxanthine-guanine phosphoribosyltransferase-deficient variants of PC12 cells. Journal of Neurochemistry 47(1): 107-112
Van Kammen, D.P.; van Kammen, W.B.; Mann, L.S.; Seppala, T.; Linnoila, M. 1986: Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. Archives of General Psychiatry 43(10): 978-983
Hutson, P.H.; Curzon, G. 1986: Dopamine metabolites in rat cisternal cerebrospinal fluid: major contribution from extrastriatal dopamine neurones. Journal of Neurochemistry 46(1): 186-190
Pothos, E.; Rada, P.; Mark, G.P.; Hoebel, B.G. 1991: Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Research 566(1-2): 348-350
Ferriani, R.A.; Silva de Sá, M.F.; Moura, M.D.; Moreira, A.C.; Gomes, U.A. 1989: Dopamine might not be involved in the pathogenesis of polycystic ovary syndrome. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 3(4): 317-327
Witkovsky, P.; Stone, S.; Besharse, J.C. 1988: Dopamine modifies the balance of rod and cone inputs to horizontal cells of the Xenopus retina. Brain Research 449(1-2): 332-336
Beauregard, M.; Ferron, A. 1991: Dopamine modulates the inhibition induced by GABA in rat cerebral cortex: an iontophoretic study. European Journal of Pharmacology 205(3): 225-231
Bianchi, C.; Tanganelli, S.; Beani, L. 1979: Dopamine modulation of acetylcholine release from the guinea-pig brain. European Journal of Pharmacology 58(3): 235-246
Altar, C.A.; Boyar, W.C.; Wasley, A.; Gerhardt, S.C.; Liebman, J.M.; Wood, P.L. 1988: Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists. Naunyn-Schmiedeberg's Archives of Pharmacology 338(2): 162-168
Triarhou, L.C.; Low, W.C.; Ghetti, B. 1990: Dopamine neurone grafting to the weaver mouse neostriatum. Progress in Brain Research 82: 187-195
Brundin, P.; Strecker, R.E.; Londos, E.; Björklund, A. 1987: Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion. Experimental Brain Research 69(1): 183-194
Butcher, L.L.; Marchand, R. 1978: Dopamine neurons in pars compacta of the substantia nigra contain acetylcholinesterase: histochemical correlations on the same brain section. European Journal of Pharmacology 52(3-4): 415-417
Romo, R.; Schultz, W. 1990: Dopamine neurons of the monkey midbrain: contingencies of responses to active touch during self-initiated arm movements. Journal of Neurophysiology 63(3): 592-606
Schultz, W.; Romo, R. 1990: Dopamine neurons of the monkey midbrain: contingencies of responses to stimuli eliciting immediate behavioral reactions. Journal of Neurophysiology 63(3): 607-624
Wolf, M.E.; Roth, R.H. 1987: Dopamine neurons projecting to the medial prefrontal cortex possess release-modulating autoreceptors. Neuropharmacology 26(8): 1053-1059
Lucatello, A.; Sturani, A.; Cocchi, R.; Fusaroli, M. 1992: Dopamine plus frusemide in cocaine-associated acute myoglobinuric renal failure. Nephron 60(2): 242-243
Raftery, A.T.; Johnson, R.W. 1979: Dopamine pretreatment in unstable kidney donors. British Medical Journal 1(6162): 522
Hughes, A.D.; Thom, S.A.; Woodall, N.M.; Redman, D.; Sever, P.S. 1987: Dopamine produces forearm vasodilatation following alpha-adrenoceptor blockade by an action on vascular dopamine (DA1) receptors in man. Journal of Hypertension 5(3): 337-340
Westerink, B.H.; Damsma, G.; De Vries, J.B.; Koning, H. 1987: Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat. European Journal of Pharmacology 135(2): 123-128
Okuda, M.; Togashi, S. 1990: Dopamine receptor. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 35(4 Suppl): 707-717
Mileson, B.E.; Lewis, M.H.; Mailman, R.B. 1991: Dopamine receptor 'supersensitivity' occurring without receptor up-regulation. Brain Research 561(1): 1-10
Borgundvaag, B.; Kudlow, J.E.; Mueller, S.G.; George, S.R. 1992: Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor-alpha gene expression and growth in anterior pituitary, but not in uterus. Endocrinology 130(6): 3453-3458
Kaiser, C.; Dandridge, P.A.; Garvey, E.; Flaim, K.E.; Zeid, R.L.; Hieble, J.P. 1985: Dopamine receptor agonist activity of some 5-(2-aminoethyl)carbostyril derivatives. Journal of Medicinal Chemistry 28(12): 1803-1810
Ilhan, M.; Flynn, J.R.; Long, J.P.; Bhatnagar, R.K.; Cannon, J.G. 1985: Dopamine receptor agonistic activities of R- and S-enantiomers of 4-hydroxy-2-di-n-propylaminoindan in cat hearts. Journal of Pharmacy and Pharmacology 37(5): 364-365
Kohli, J.D. 1990: Dopamine receptor agonists and antagonists. Proceedings of the Western Pharmacology Society 33: 21-27
Inoue, K.; Nakazawa, K.; Watano, T.; Ohara-Imaizumi, M.; Fujimori, K.; Takanaka, A. 1992: Dopamine receptor agonists and antagonists enhance ATP-activated currents. European Journal of Pharmacology 215(2-3): 321-324
Sahin, I.; Tuncer, M.; Ilhan, M. 1990: Dopamine receptor agonists, N,N-dipropyl-2-aminotetralin (TL-68) and 2-di-n-propylamino-4,7-dimethoxyindane (RDS-127) antagonize oxotremorine-induced tremors by antimuscarinic action in mice. Archives Internationales de Physiologie et de Biochimie 98(1): 7-9
Ross, S.T.; Franz, R.G.; Wilson, J.W.; Brenner, M.; DeMarinis, R.M.; Hieble, J.P.; Sarau, H.M. 1986: Dopamine receptor agonists: 3-allyl-6-chloro-2,3,4,5-tetrahydro- 1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol and a series of related 3-benzazepines. Journal of Medicinal Chemistry 29(5): 733-740
Clark, D.; Hjorth, S.; Carlsson, A. 1985: Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. Journal of Neural Transmission 62(3-4): 171-207
Andersen, P.H.; Jansen, J.A. 1990: Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. European Journal of Pharmacology 188(6): 335-347
Rotrosen, J.; Angrist, B.M.; Gershon, S.; Sachar, E.J.; Halpern, F.S. 1976: Dopamine receptor alteration in schizophrenia: neuroendocrine evidence. Psychopharmacology 51(1): 1-7
Judd, A.M.; MacLeod, R.M. 1991: Dopamine receptor and adrenoceptor agonists inhibit prolactin release from MMQ cells. European Journal of Pharmacology 195(1): 101-106
Krowicki, Z.K. 1991: Dopamine receptor antagonists block the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia. Neuropeptides 19(4): 281-285
Kawagishi, S.; Yoshino, K.; Jones, T.E.; Iwamoto, M.; Arai, S.; Amano, N. 1992: Dopamine receptor antagonists increase markedly the quantity of retrograde transport of HRP in the rat masseteric motoneuron. Brain Research 585(1-2): 196-204
Reynolds, G.P.; Czudek, C.; Bzowej, N.; Seeman, P. 1987: Dopamine receptor asymmetry in schizophrenia. Lancet 1(8539): 979
Creese, I.; Burt, D.R.; Snyder, S.H. 1977: Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science 197(4303): 596-598
Burt, D.R.; Enna, S.J.; Creese, I.; Snyder, S.H. 1975: Dopamine receptor binding in the corpus striatum of mammalian brain. Proceedings of the National Academy of Sciences of the United States of America 72(11): 4655-4659
Creese, I.; Snyder, S.H. 1978: Dopamine receptor binding of 3H-ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) regulated by guanyl nucleotides. European Journal of Pharmacology 50(4): 459-461
Wong, D.F.; Wagner, H.N.; Pearlson, G.; Dannals, R.F.; Links, J.M.; Ravert, H.T.; Wilson, A.A.; Suneja, S.; Bjorvvinssen, E.; Kuhar, M.J. 1985: Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report. Psychopharmacology Bulletin 21(3): 595-598
Gyüre, K.; Szentendrei, T.; Kanyicska, B.; Fekete, M.I.; Rónai, A.Z. 1985: Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509. Polish Journal of Pharmacology and Pharmacy 37(3): 253-261
Creese, I.; Burt, D.R.; Snyder, S.H. 1975: Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol. Life Sciences 17(6): 933-1001
Fletcher, P.J. 1991: Dopamine receptor blockade in nucleus accumbens or caudate nucleus differentially affects feeding induced by 8-OH-DPAT injected into dorsal or median raphe. Brain Research 552(2): 181-189
Chapman, B.J.; Horn, N.M.; Munday, K.A.; Robertson, M.J. 1978: Dopamine receptor blockade in the rat kidney. Journal of Physiology 278: 37P-38P
Yamada, K.; Matsuo, N.; Nagashima, M.; Kumagai, M.; Furukawa, T. 1989: Dopamine receptor blocking action of a dibenzothiepin derivative isofloxythepin in rats. Clinical and Experimental Pharmacology and Physiology 16(2): 109-116
Groppetti, A.; Flauto, C.; Parati, E.; Vescovi, A.; Rusconi, L.; Parenti, M. 1986: Dopamine receptor changes in response to prolonged treatment with L-dopa. Journal of Neural Transmission. Supplementum 22: 33-45
Alexander, G.M.; Brainard, D.L.; Gordon, S.W.; Hichens, M.; Grothusen, J.R.; Schwartzman, R.J. 1991: Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primates. Brain Research 547(2): 181-189
Seeman, P.; Guttman, M. 1987: Dopamine receptor elevation in denervated tissues. Annals of Neurology 21(4): 412-415
Laihinen, A.; Rinne, U.K. 1987: Dopamine receptor function in Parkinson's disease--in vivo studies with prolactin responses. Advances in Neurology 45: 249-252
Robertson, H.A. 1992: Dopamine receptor interactions: some implications for the treatment of Parkinson's disease. Trends in Neurosciences 15(6): 201-206
Verma, A.; Kulkarni, S.K. 1991: Dopamine receptor mediated hypothermic action of B-HT 920 in rats. Journal of Pharmacy and Pharmacology 43(6): 421-424
Johnson, R.L.; Rajakumar, G.; Mishra, R.K. 1986: Dopamine receptor modulation by Pro-Leu-Gly-NH2 analogues possessing cyclic amino acid residues at the C-terminal position. Journal of Medicinal Chemistry 29(10): 2100-2104
Yu, K.L.; Rajakumar, G.; Srivastava, L.K.; Mishra, R.K.; Johnson, R.L. 1988: Dopamine receptor modulation by conformationally constrained analogues of Pro-Leu-Gly-NH2. Journal of Medicinal Chemistry 31(7): 1430-1436
Wolkin, A.; Brodie, J.D.; Barouche, F.; Rotrosen, J.; Wolf, A.P.; Smith, M.; Fowler, J.; Cooper, T.B. 1989: Dopamine receptor occupancy and plasma haloperidol levels. Archives of General Psychiatry 46(5): 482-484
Nielsen, E.B.; Andersen, P.H. 1992: Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists. European Journal of Pharmacology 219(1): 35-44
Saller, C.F.; Kreamer, L.D.; Adamovage, L.A.; Salama, A.I. 1989: Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Life Sciences 45(10): 917-929
Weihmuller, F.B.; Bruno, J.P.; Neff, N.H.; Hadjiconstantinou, M. 1990: Dopamine receptor plasticity following MPTP-induced nigrostriatal lesions in the mouse. European Journal of Pharmacology 180(2-3): 369-372
Hägglund, J.; Aquilonius, S.M.; Eckernäs, S.A.; Hartvig, P.; Lundquist, H.; Gullberg, P.; Långström, B. 1987: Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone. Acta Neurologica Scandinavica 75(2): 87-94
Anokhina, I.P.; Ivanets, N.N.; Reshchikova, E.V.; Nebarakova, T.P. 1988: Dopamine receptor stimulants in the treatment of alcoholism. Sovetskaia Meditsina 8: 93-95
Shopsin, B.; Gershon, S. 1978: Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495). Neuropsychobiology 4(1): 1-14
De Vlieger, T.A.; Lodder, J.C.; Stoof, J.C.; Werkman, T.R. 1986: Dopamine receptor stimulation induces a potassium dependent hyperpolarizing response in growth hormone producing neuroendocrine cells of the gastropod mollusc Lymnaea stagnalis. Comparative Biochemistry and Physiology. C Comparative Pharmacology and Toxicology 83(2): 429-433
Goldberg, L.I. 1987: Dopamine receptor subtypes and hypertension. Clinical and Experimental Hypertension. Part A Theory and Practice 9(5-6): 833-836
Andersen, P.H.; Gingrich, J.A.; Bates, M.D.; Dearry, A.; Falardeau, P.; Senogles, S.E.; Caron, M.G. 1990: Dopamine receptor subtypes: beyond the D1/D2 classification. Trends in Pharmacological Sciences 11(6): 231-236
Clement-Cormier, Y.C.; Meyerson, L.R.; Phillips, H.; Davis, V.E. 1979: Dopamine receptor topography. Characterization of antagonist requirements of striatal dopamine-sensitive adenylate cyclase using protoberberine alkaloids. Biochemical Pharmacology 28(20): 3123-3129
Miller, J.C.; Friedhoff, A.J. 1979: Dopamine receptor-coupled modulation of the K+-depolarized overflow of 3H-acetylcholine from rat striatal slices: alteration after chronic haloperidol and alpha-methyl-p-tyrosine pretreatment. Life Sciences 25(14): 1249-1255
Vyas, S.J.; Jadhav, A.L.; Eichberg, J.; Lokhandwala, M.F. 1992: Dopamine receptor-mediated activation of phospholipase C is associated with natriuresis during high salt intake. American Journal of Physiology 262(3 Part 2): F494-F498
Hjorth, S.; Carlsson, A.; Clark, D.; Svensson, K.; Sanchez, D. 1985: Dopamine receptor-mediated hypothermia induced in rats by (+)-, but not by (-)-3-PPP. European Journal of Pharmacology 107(3): 299-304
Iuvone, P.M.; Besharse, J.C. 1986: Dopamine receptor-mediated inhibition of serotonin N-acetyltransferase activity in retina. Brain Research 369(1-2): 168-176
Barasi, S.; Ben-Sreti, M.M.; Clatworthy, A.L.; Duggal, K.N.; Gonzalez, J.P.; Robertson, J.; Rooney, K.F.; Sewell, R.D. 1987: Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390. British Journal of Pharmacology 90(1): 15-22
Schorderet, M.; McDermed, J.; Magistretti, P. 1978: Dopamine receptors and cyclic AMP in rabbit retina: a pharmacological and stereochemical analysis using semi-rigid analogs of dopamine (aminotetralins) and thioxanthene isomers. Journal de Physiologie 74(5): 509-513
Sano, K.; Noshiro, O.; Katsuda, K.; Nishikori, K.; Maeno, H. 1979: Dopamine receptors and dopamine-sensitive adenylate cyclase in canine caudate nucleus. Characterization and solubilization. Biochemical Pharmacology 28(24): 3617-3627
Fuxe, K.; Fredholm, B.B.; Agnati, L.F.; Corrodi, H. 1978: Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors. Brain Research 146(2): 295-311
Weihmuller, F.B.; Hadjiconstantinou, M.; Bruno, J.P. 1990: Dopamine receptors and sensorimotor behavior in MPTP-treated mice. Behavioural Brain Research 38(3): 263-273
Seeman, P. 1987: Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1(2): 133-152
Sakai, Y.; Sekiguchi, M.; Okamoto, K.; Kuwano, R.; Takahashi, Y. 1990: Dopamine receptors expressed in the Xenopus oocytes injected with bovine striatal mRNA. Brain Research. Molecular Brain Research 7(2): 183-187
Flemenbaum, A. 1977: Dopamine receptors hypersensitivity: further confirmation following drug abuse model. Advances in Experimental Medicine and Biology 90: 207-217
Guttman, M. 1992: Dopamine receptors in Parkinson's disease. Neurologic Clinics 10(2): 377-386
Cortés, R.; Camps, M.; Gueye, B.; Probst, A.; Palacios, J.M. 1989: Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology. Brain Research 483(1): 30-38
Cortés, R.; Gueye, B.; Pazos, A.; Probst, A.; Palacios, J.M. 1989: Dopamine receptors in human brain: autoradiographic distribution of D1 sites. Neuroscience 28(2): 263-273
Camps, M.; Cortés, R.; Gueye, B.; Probst, A.; Palacios, J.M. 1989: Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience 28(2): 275-290
Kumar, B.V.; Sastry, P.S. 1992: Dopamine receptors in human foetal brains: characterization, regulation and ontogeny of [3H]spiperone binding sites in striatum. Neurochemistry International 20(4): 559-566
Lloyd, R.V.; Anagnostou, D.; Chandler, W.F. 1988: Dopamine receptors in immunohistochemically characterized null cell adenomas and normal human pituitaries. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 1(1): 51-56
Muhr, C.; Bergström, M.; Lundberg, P.O.; Bergström, K.; Hartvig, P.; Lundqvist, H.; Antoni, G.; Långström, B. 1986: Dopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperone. Journal of Computer Assisted Tomography 10(2): 175-180
Elena, P.P.; Denis, P.; Kosina-Boix, M.; Lapalus, P. 1989: Dopamine receptors in rabbit and rat eye: characterization and localization of DA1 and DA2 binding sites. Current Eye Research 8(1): 75-83
Amenta, F.; De Rossi, M.; Ricci, A.; Amenta, D. 1987: Dopamine receptors in the cardiocirculatory system: an autoradiographic study. Cardiologia 32(12): 1609-1612
Amenta, F.; Ricci, A. 1991: Dopamine receptors in the cardiovascular system. Functional Neurology 6(3): 219-222
Izquierdo, I. 1992: Dopamine receptors in the caudate nucleus and memory processes. Trends in Pharmacological Sciences 13(1): 7-8
Cox, B.; Kerwin, R.; Lee, T.F. 1978: Dopamine receptors in the central thermoregulatory pathways of the rat. Journal of Physiology 282: 471-483
Felder, R.A.; Nakamura, K.T.; Robillard, J.E.; Kanadjian, M.; Jose, P.A. 1988: Dopamine receptors in the developing sheep kidney. Pediatric Nephrology 2(1): 156-162
Laubie, M.; Schmitt, H.; Falq, E. 1977: Dopamine receptors in the femoral vascular bed of the dog as mediators of a vasodilator and sympathoinhibitory effect. European Journal of Pharmacology 42(3): 307-310
Ricci, A.; Zaccheo, D.; Amenta, F. 1991: Dopamine receptors in the rat thymus. Functional Neurology 6(3): 223-225
Seeman, P.; Schaus, J.M. 1991: Dopamine receptors labelled by [3H]quinpirole. European Journal of Pharmacology 203(1): 105-109
Nylander, I.; Terenius, L.H. 1987: Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways. Neuropharmacology 26(9): 1295-1302
Rockhold, R.W.; Carver, E.S.; Ishizuka, Y.; Hoskins, B.; Ho, I.K. 1991: Dopamine receptors mediate cocaine-induced temperature responses in spontaneously hypertensive and Wistar-Kyoto rats. Pharmacology Biochemistry and Behavior 40(1): 157-162
Carey, R.J. 1990: Dopamine receptors mediate drug-induced but not Pavlovian conditioned contralateral rotation in the unilateral 6-OHDA animal model. Brain Research 515(1-2): 292-298
Ricci, A.; Collier, W.L.; Rossodivita, I.; Amenta, F. 1991: Dopamine receptors mediating inhibition of the cyclic adenosine monophosphate generating system in the rat renal cortex. Journal of Autonomic Pharmacology 11(2): 121-127
Naumenko, E.V.; Serova, L.I. 1975: Dopamine receptors of the diencephalon associated with the endocrine function of the hypophyseal-testicular system. Problemy Endokrinologii 21(6): 53-56
Komissarov, I.V.; Krivobok, G.K.; Makarova, L.E. 1975: Dopamine receptors of the smooth muscles. Farmakologiia i Toksikologiia 38(4): 419-423
Brann, M.R.; Jelsema, C.L. 1985: Dopamine receptors on photoreceptor membranes couple to a GTP-binding protein which is sensitive to both pertussis and cholera toxin. Biochemical and Biophysical Research Communications 133(1): 222-227
George, S.R.; Kertesz, M. 1985: Dopamine receptors regulate Met-enkephalin content in pituitary. Brain Research 334(1): 187-189
Beart, P.M. 1989: Dopamine receptors: classification, properties and drug development. Clinical and Experimental Pharmacology and Physiology 16(6): 511-515
Kaiser, C.; Jain, T. 1985: Dopamine receptors: functions, subtypes and emerging concepts. Medicinal Research Reviews 5(2): 145-229
Stoof, J.C. 1986: Dopamine receptors: fundamental and clinical aspects. Nederlands Tijdschrift Voor Geneeskunde 130(37): 1638-1642
Garau, L.; Govoni, S.; Stefanini, E.; Trabucchi, M.; Spano, P.F. 1978: Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sciences 23(17-18): 1745-1750
Nelson, S.H.; Steinsland, O.S. 1985: Dopamine receptors: structure-activity relationship of d-tubocurarine analogues. European Journal of Pharmacology 108(2): 209-212
Witzgall, H.; Lorenz, R.; von Werder, K.; Weber, P.C. 1985: Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin Ii in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. Clinical Science 68(3): 291-299
Pritchett, D.B.; Roberts, J.L. 1987: Dopamine regulates expression of the glandular-type kallikrein gene at the transcriptional level in the pituitary. Proceedings of the National Academy of Sciences of the United States of America 84(16): 5545-5549
Valentijn, J.A.; Louiset, E.; Vaudry, H.; Cazin, L. 1991: Dopamine regulates the electrical activity of frog melanotrophs through a G protein-mediated mechanism. Neuroscience 44(1): 85-95
Kusunoki, M.; Taniyama, K.; Tanaka, C. 1985: Dopamine regulation of [3H]acetylcholine release from guinea-pig stomach. Journal of Pharmacology and Experimental Therapeutics 234(3): 713-719
Raiteri, M.; Marchi, M.; Bonanno, G.; Fedele, E.; Versace, P. 1992: Dopamine release and dopaminergic inhibition of acetylcholine release in rat striatal slices after nigro-striatal hemitransection and parenteral ganglioside administration. European Journal of Pharmacology 213(1): 17-24
Imperato, A.; Di Chiara, G. 1985: Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 5(2): 297-306
Bell, C. 1988: Dopamine release from sympathetic nerve terminals. Progress in Neurobiology 30(2-3): 193-208
Tagerud, S.E.; Cuello, A.C. 1979: Dopamine release from the rat substantia nigra in vitro. Effect of raphe lesions and veratridine stimulation. Neuroscience 4(12): 2021-2029
Radhakishun, F.S.; Westerink, B.H.; van Ree, J.M. 1988: Dopamine release in the nucleus accumbens of freely moving rats determined by on-line dialysis: effects of apomorphine and the neuroleptic-like peptide desenkephalin-gamma-endorphin. Neuroscience Letters 89(3): 328-334
Imperato, A.; Honoré, T.; Jensen, L.H. 1990: Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats. Brain Research 530(2): 223-228
Wood, P.L.; Altar, C.A. 1988: Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: utility of 3-methoxytyramine measurements. Pharmacological Reviews 40(3): 163-187
Nordström, O.; Braesch-Andersen, S.; Bartfai, T. 1986: Dopamine release is enhanced while acetylcholine release is inhibited by nimodipine (Bay e 9736). Acta Physiologica Scandinavica 126(1): 115-119
Kato, S.; Ishita, S.; Mawatari, K.; Matsukawa, T.; Negishi, K. 1990: Dopamine release via protein kinase C activation in the fish retina. Journal of Neurochemistry 54(6): 2082-2090
Melchior, C.L.; Simpson, C.W.; Myers, R.D. 1978: Dopamine release within forebrain sites perfused with tetrahydroisoquinolines or tryptoline in the rat. Brain Research Bulletin 3(6): 631-634
Carder, R.K.; Jackson, D.; Morris, H.J.; Lund, R.D.; Zigmond, M.J. 1989: Dopamine released from mesencephalic transplants restores modulation of striatal acetylcholine release after neonatal 6-hydroxydopamine: an in vitro analysis. Experimental Neurology 105(3): 251-259
Benuck, M.; Reith, M.E. 1992: Dopamine releasing effect of phenylbiguanide in rat striatal slices. Naunyn-Schmiedeberg's Archives of Pharmacology 345(6): 666-672
Missale, C.; Memo, M.; Liberini, P.; Spano, P. 1988: Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors. Journal of Pharmacology and Experimental Therapeutics 246(3): 1137-1143
Babichev, V.N.; Ignatkov, V.I. 1977: Dopamine sensitive neurons of the arcuate region of the hypothalamus and their role in regulating the gonadotropic function of the pituitary. Biulleten' Eksperimental'noi Biologii i Meditsiny 84(11): 518-521
McMillian, M.K.; He, X.P.; Hong, J.S.; Pennypacker, K.R. 1992: Dopamine stimulates [3H]phorbol 12,13-dibutyrate binding in cultured striatal cells. Journal of Neurochemistry 58(4): 1308-1312
Lewis, B.M.; Dieguez, C.; Lewis, M.D.; Scanlon, M.F. 1987: Dopamine stimulates release of thyrotrophin-releasing hormone from perfused intact rat hypothalamus via hypothalamic D2-receptors. Journal of Endocrinology 115(3): 419-424
Cappiello, M.; Giuliani, L.; Rane, A.; Pacifici, G.M. 1991: Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in the human fetus. Developmental Pharmacology and Therapeutics 16(2): 83-88
LaHoste, G.J.; Marshall, J.F. 1992: Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. Synapse 12(1): 14-26
Reid, J.L. 1975: Dopamine supersensitivity in the hypothalamus?. Advances in Neurology 9: 73-80
Horrobin, D.F. 1978: Dopamine supersensitivity, endorphin excess, and prostaglandin E1 deficiency: three aspects of the same schizophrenic elephant. Schizophrenia Bulletin 4(4): 487-488
Iuvone, P.M.; Tigges, M.; Fernandes, A.; Tigges, J. 1989: Dopamine synthesis and metabolism in rhesus monkey retina: development, aging, and the effects of monocular visual deprivation. Visual Neuroscience 2(5): 465-471
Dawson, R.; Phillips, M.I. 1990: Dopamine synthesis and release in LLC-PK1 cells. European Journal of Pharmacology 189(6): 423-426
Patrick, R.L.; Barchas, J.D. 1976: Dopamine synthesis in rat brain striatal synaptosomes. I. Correlations between veratridine-induced synthesis stimulation and endogenous dopamine release. Journal of Pharmacology and Experimental Therapeutics 197(1): 89-96
Patrick, R.L.; Barchas, J.D. 1976: Dopamine synthesis in rat brain striatal synaptosomes. II. Dibutyryl cyclic adenosine 3':5'-monophosphoric acid and 6-methyltetrahydropterine-induced synthesis increases without an increase in endogenous dopamine release. Journal of Pharmacology and Experimental Therapeutics 197(1): 97-104
Milner, J.D.; Reinstein, D.K.; Wurtman, R.J. 1987: Dopamine synthesis in rat striatum: mobilization of tyrosine from non-dopaminergic cells. Experientia 43(10): 1109-1110
Kalivas, P.W.; Stewart, J. 1991: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Research. Brain Research Reviews 16(3): 223-244
Grigoriadis, D.E.; Wilson, A.A.; Lew, R.; Sharkey, J.S.; Kuhar, M.J. 1989: Dopamine transport sites selectively labeled by a novel photoaffinity probe: 125I-DEEP. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 9(8): 2664-2670
Shimada, S.; Kitayama, S.; Walther, D.; Uhl, G. 1992: Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Brain Research. Molecular Brain Research 13(4): 359-362
Kitayama, S.; Shimada, S.; Xu, H.; Markham, L.; Donovan, D.M.; Uhl, G.R. 1992: Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proceedings of the National Academy of Sciences of the United States of America 89(16): 7782-7785
Lew, R.; Grigoriadis, D.; Wilson, A.; Boja, J.W.; Simantov, R.; Kuhar, M.J. 1991: Dopamine transporter: deglycosylation with exo- and endoglycosidases. Brain Research 539(2): 239-246
Uhl, G.R.; O'Hara, B.; Shimada, S.; Zaczek, R.; DiGiorgianni, J.; Nishimori, T. 1991: Dopamine transporter: expression in Xenopus oocytes. Brain Research. Molecular Brain Research 9(1-2): 23-29
Rasmussen, K.T.; Jørgensen, E.O. 1985: Dopamine treatment in cardiogenic shock. Ugeskrift for Laeger 147(26): 2089-2090
Fowler, C.J.; Magnusson, O.; Thorell, G.; Mohringe, B.; Huang, R.B. 1987: Dopamine turnover and glutamate decarboxylase activity in the rat brain after acute and chronic treatment with raclopride, a dopamine D2-selective antagonist. Neuropharmacology 26(4): 339-345
Spina, M.B.; Cohen, G. 1989: Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America 86(4): 1398-1400
Barkai, A.I. 1978: Dopamine turnover in the intact rabbit brain: effect of pentobarbital or haloperidol. Journal of Pharmacology and Experimental Therapeutics 205(1): 133-140
Neff, N.H.; Galli, C.L.; Costa, E. 1977: Dopamine turnover: studies with 18O2. Advances in Biochemical Psychopharmacology 16: 187-192
Ricaurte, G.A.; Langston, J.W.; DeLanney, L.E.; Irwin, I.; Brooks, J.D. 1985: Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum. Neuroscience Letters 59(3): 259-264
Dean, B.; Copolov, D.L. 1989: Dopamine uptake by platelets is selective, temperature dependent and not influenced by the dopamine-D1 or dopamine-D2 receptor. Life Sciences 45(5): 401-411
Woodward, J.J.; Wilcox, R.E.; Leslie, S.W.; Riffee, W.H. 1986: Dopamine uptake during fast-phase endogenous dopamine release from mouse striatal synaptosomes. Neuroscience Letters 71(1): 106-112
Mercuri, N.B.; Calabresi, P.; Bernardi, G. 1991: Dopamine uptake inhibition potentiates the effects of L-DOPA on rat substantia nigra zona compacta neurons. Neuroscience Letters 126(1): 79-82
Marek, G.J.; Vosmer, G.; Seiden, L.S. 1990: Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Research 513(2): 274-279
Drucker, G.; Raikoff, K.; Neafsey, E.J.; Collins, M.A. 1990: Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation products. Brain Research 509(1): 125-133
Tucker, S.C. 1987: Dopamine use in neonates. Neonatal Network: Nn 6(2): 21-24
Godden, U.; Holzbauer, M.; Sharman, D.F. 1977: Dopamine utilization in the posterior pituitary gland of the rat. British Journal of Pharmacology 59(3): 478P-479P
Kohli, J.D.; Goldberg, L.I.; Nichols, D.E. 1979: Dopamine vascular actions of N-substituted derivatives of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN). European Journal of Pharmacology 56(1-2): 39-44
Stephenson, L.W.; Blackstone, E.H.; Kouchoukos, N.T. 1976: Dopamine vs epinephrine in patients following cardiac surgery: randomized study. Surgical Forum 27(62): 272-275
Aghajanian, G.K.; Bunney, B.S. 1977: Dopamine"autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies. Naunyn-Schmiedeberg's Archives of Pharmacology 297(1): 1-7
Ebadi, M.; Hama, Y. 1988: Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia. Neuroscience and Biobehavioral Reviews 12(3-4): 179-187
Cooper, D.M.; Bier-Laning, C.M.; Halford, M.K.; Ahlijanian, M.K.; Zahniser, N.R. 1986: Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process. Molecular Pharmacology 29(2): 113-119
Agnoli, G.C.; Cacciari, M.; Cariani, A.; Garutti, C.; Lenzi, P. 1978: Dopamine, catecholamine receptors, and neurohumoral regulation of renal function. Archivio di Scienze Biologiche 62(1-4): 83-129
Kuchel, O.; Hamet, P. 1977: Dopamine, extracellular cyclic AMP and sodium excretion. European Journal of Clinical Investigation 7(1): 75-76
Yoshimura, M. 1985: Dopamine, its regulation of hormone secretion and its clinical significance. Rinsho Byori. Japanese Journal of Clinical Pathology 33(5): 509-512
Fekete, M.I.; Herman, J.P.; Kanyicska, B.; Palkovits, M. 1979: Dopamine, noradrenaline and 3,4-dihydroxyphenylacetic acid (DOPAC) levels of individual brain nuclei, effects of haloperidol and pargyline. Journal of Neural Transmission 45(3): 207-218
Swyer, G. 1976: Dopamine, prolactin, and bromocryptine. Nursing Mirror and Midwives Journal 143(12): 65-66
Rathbun, W.; Druse, M.J. 1985: Dopamine, serotonin, and acid metabolites in brain regions from the developing offspring of ethanol-treated rats. Journal of Neurochemistry 44(1): 57-62
Wood, D.F.; Johnston, J.M.; Johnston, D.G. 1991: Dopamine, the dopamine D2 receptor and pituitary tumours. Clinical Endocrinology 35(6): 455-466
Lee, M.R. 1989: Dopamine, the kidney and essential hypertension. Clinical and Experimental Hypertension. Part A Theory and Practice 11(Suppl 1): 149-158
Lee, M.R. 1987: Dopamine, the kidney and essential hypertension studies with gludopa. Clinical and Experimental Hypertension. Part A Theory and Practice 9(5-6): 977-986
Sicuteri, F. 1977: Dopamine, the second putative protagonist in headache. Headache 17(3): 129-131
Meister, B.; Schultzberg, M.; Hemmings, H.C.; Greengard, P.; Goldstein, M.; Hökfelt, T. 1991: Dopamine- and adenosine-3',5'-monophosphate (cAMP)-regulated phosphoprotein of 32 kDa (DARPP-32) in the adrenal gland: immunohistochemical localization. Journal of the Autonomic Nervous System 36(1): 75-84
Meister, B.; Arvidsson, U.; Hemmings, H.C.; Greengard, P.; Hökfelt, T. 1991: Dopamine- and adenosine-3':5'-monophosphate (cAMP)-regulated phosphoprotein of Mr 32,000 (DARPP-32) in the retina of cat, monkey and human. Neuroscience Letters 131(1): 66-70
Bucher, M.B.; Schorderet, M. 1975: Dopamine- and apomorphine-sensitive adenylate cyclase in homogenates of rabbit retina. Naunyn-Schmiedeberg's Archives of Pharmacology 288(1): 103-107
Kitahama, K.; Geffard, M.; Okamura, H.; Nagatsu, I.; Mons, N.; Jouvet, M. 1990: Dopamine- and dopa-immunoreactive neurons in the cat forebrain with reference to tyrosine hydroxylase-immunohistochemistry. Brain Research 518(1-2): 83-94
Awoke, S.; Perlstein, R.S. 1985: Dopamine- and norepinephrine-secreting intrapericardial pheochromocytoma in a normotensive patient. Southern Medical Journal 78(8): 994-998
Pratt, S.; Pryor, S.C. 1986: Dopamine- and octopamine-sensitive adenylate cyclase in the brain of adult Culex pipiens mosquitoes. Cellular and Molecular Neurobiology 6(3): 325-329
Stephens, D.N.; Herberg, L.J. 1979: Dopamine--acetylcholine "balance" in nucleus accumbens and corpus striatum and its effect on hypothalamic self-stimulation. European Journal of Pharmacology 54(4): 331-339
Hadfield, M.G.; Rigby, W.F. 1976: Dopamine--adaptive uptake changes in striatal synaptosomes after 30 sec of shock-induced fighting. Biochemical Pharmacology 25(24): 2752-2754
Carey, R.M.; Siragy, H.M.; Ragsdale, N.V.; Howell, N.L.; Felder, R.A.; Peach, M.J.; Chevalier, R.L. 1990: Dopamine-1 and dopamine-2 mechanisms in the control of renal function. American Journal of Hypertension 3(6 Part 2): 59s-63s
Kinoshita, S.; Ohlstein, E.H.; Felder, R.A. 1990: Dopamine-1 receptors in rat proximal convoluted tubule: regulation by intrarenal dopamine. American Journal of Physiology 258(4 Part 2): F1068-F1074
Felder, C.C.; Blecher, M.; Jose, P.A. 1989: Dopamine-1-mediated stimulation of phospholipase C activity in rat renal cortical membranes. Journal of Biological Chemistry 264(15): 8739-8745
Mekki, Q.A.; Turner, P. 1988: Dopamine-2 receptor blockade does not affect the ocular hypotensive action of timolol. British Journal of Ophthalmology 72(8): 598-600
Buu, N.T.; Kuchel, O. 1979: Dopamine-4-O-sulfate: a possible precursor of free norepinephrine. Canadian Journal of Biochemistry 57(9): 1159-1162
Simpson, C.W.; Cummins, C.; Dicara, L.V. 1975: Dopamine-B-hydroxylase activity in rat hypothalamus during the estrus cycle. Pharmacology Biochemistry and Behavior 3(4): 693-696
Micheau, C.; Guerinot, F.; Bohuon, C.; Brugere, J. 1975: Dopamine-B-hydroxylase and catecholamines in an olfactory esthesioneuroma. Cancer 35(5): 1309-1312
Onténiente, B.; Simon, H.; Taghzouti, K.; Geffard, M.; Le Moal, M.; Calas, A. 1987: Dopamine-GABA interactions in the nucleus accumbens and lateral septum of the rat. Brain Research 421(1-2): 391-396
Dacey, D.M. 1988: Dopamine-accumulating retinal neurons revealed by in vitro fluorescence display a unique morphology. Science 240(4856): 1196-1198
Chang, H.T. 1988: Dopamine-acetylcholine interaction in the rat striatum: a dual-labeling immunocytochemical study. Brain Research Bulletin 21(2): 295-304
Westerink, B.H.; de Boer, P.; Damsma, G. 1990: Dopamine-acetylcholine interaction in the striatum studied by microdialysis in the awake rat: some methodological aspects. Journal of Neuroscience Methods 34(1-3): 117-124
McGeer, P.L.; McGeer, E.G.; Hattori, T. 1977: Dopamine-acetylcholine-GABA neuronal linkages in the extrapyramidal and limbic systems. Advances in Biochemical Psychopharmacology 16: 397-402
Savoldi, F.; Tartara, A.; Bo, P. 1979: Dopamine-agonist drugs and cerebral electrical activity in the rabbit. Il Farmaco; Edizione Scientifica 34(6): 526-534
Yamazaki, N.; Ogawa, K. 1976: Dopamine-beta-hydroxylase (DBH). Kokyu to Junkan. Respiration and Circulation 24(11): 949-955
Garnier, C.; Comoy, E.; Barthelemy, C.; Leddet, I.; Garreau, B.; Muh, J.P.; Lelord, G. 1986: Dopamine-beta-hydroxylase (DBH) and homovanillic acid (HVA) in autistic children. Journal of Autism and Developmental Disorders 16(1): 23-29
Ogawa, K.; Yamazaki, N.; Suzuki, Y.; Sassa, H. 1977: Dopamine-beta-hydroxylase activity after acute myocardial infarction. Japanese Heart Journal 18(3): 348-356
Planz, G.; Corr, H.; Gierlichs, H.W.; Hawlina, A.; Planz, R.; Stephany, W.; Rahn, K.H. 1975: Dopamine-beta-hydroxylase activity and catecholamine concentration in plasma as a parameter of sympathetic tonus: effect of the ergometric test on patients with normotension and essential hypertension. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1066-1068
Grobecker, H.; Saavedra, J.M.; McCarty, R.; Chiueh, C.C.; Kopin, I.J. 1977: Dopamine-beta-hydroxylase activity and catecholamine concentrations in plasma: experimental and essential hypertension. Postgraduate Medical Journal 53(Suppl): 43-48
Ksiazek, A. 1979: Dopamine-beta-hydroxylase activity and catecholamine levels in the plasma of patients with renal failure. Nephron 24(4): 170-173
García-Estañ, J.; Muñoz, J.A.; Serrano, M.C.; Carbonell, L.F.; Miras Portugal, M.T.; Quesada, T. 1985: Dopamine-beta-hydroxylase activity in adrenal gland and spleen of rats after fasting and cold exposure. Experientia 41(1): 61-62
Ben-Chetrit, E.; Gutman, A.; Levy, M. 1990: Dopamine-beta-hydroxylase activity in familial Mediterranean fever. Lancet 335(8682): 176
Muñoz, J.A.; García-Estañ, J.; Canteras, M.; Quesada, T.; Miras-Portugal, M.T. 1986: Dopamine-beta-hydroxylase activity in plasma, spleen and adrenal gland of streptozotocin-diabetic rats: correlation with cataracts. Revista Espanola de Fisiologia 42(1): 63-70
Okada, T.; Ohta, T.; Shinoda, T.; Kato, T.; Ikuta, K. 1976: Dopamine-beta-hydroxylase activity in serum and cerebrospinal fluid in neuropsychiatric diseases. Neuropsychobiology 2(2-3): 139-144
Gutteberg, T.; Borud, O.; Stromme, J.H. 1976: Dopamine-beta-hydroxylase activity in serum following acute myocardial infarction: an evaluation of this parameter for routine use as an index of sympathetic activity. Clinica Chimica Acta; International Journal of Clinical Chemistry 69(1): 61-66
Kuzuya, H.; Ikeno, T.; Ikeno, K.; Kato, T.; Nagatsu, T. 1976: Dopamine-beta-hydroxylase activity in serum of developing rats. Experientia 32(1): 16-18
Rabinowitz, R.; Korczyn, A.D.; Eshel, Y.; Rubinstein, I. 1979: Dopamine-beta-hydroxylase activity in serum of patients with hepatic damage. Progress in Neuro-Psychopharmacology 3(5-6): 551-553
Nagatsu, T.; Kato, T.; Hashimoto, Y.; Numata, Y.; Yamori, Y.; Okamoto, K. 1978: Dopamine-beta-hydroxylase activity in stroke-prone spontaneously hypertensive rats. Experientia 34(3): 305-306
Aberg, H.; Hedstrand, H.; Wetterberg, L.; Ross, S.B. 1975: Dopamine-beta-hydroxylase after treatment with beta-blockers in hypertension. International Journal of Clinical Pharmacology and Biopharmacy 11(1): 15-18
Aberg, H.; Hedstrand, H.; Wetterberg, L.; Ross, S.B. 1975: Dopamine-beta-hydroxylase and plasma renin activity in twenty hypertensive subjects. Upsala Journal of Medical Sciences 80(1): 24-26
Biaggioni, I.; Goldstein, D.S.; Atkinson, T.; Robertson, D. 1990: Dopamine-beta-hydroxylase deficiency in humans. Neurology 40(2): 370-373
Brewster, M.A.; Berry, D.H. 1979: Dopamine-beta-hydroxylase effectors in neuroblastoma. Annals of Clinical and Laboratory Science 9(4): 343-346
Galebskaia, L.V. 1978: Dopamine-beta-hydroxylase in man and animals at physiological and pathological states. Ukrainskii Biokhimicheskii Zhurnal 50(3): 381-393
Brown, F.C.; Coleman, J.H. 1975: Dopamine-beta-hydroxylase in nerve function and mental illness. Diseases of the Nervous System 36(7): 383-385
Schöni, M.H.; Türler, K.; Käser, H.; Kraemer, R. 1986: Dopamine-beta-hydroxylase in patients with cystic fibrosis. European Journal of Pediatrics 145(1-2): 80-83
Aunis, D.; Serck-Hanssen, G.; Helle, K.B. 1978: Dopamine-beta-hydroxylase in perfusates of stimulated bovine adrenals. Isolation and characterization of the released enzyme. General Pharmacology 9(1): 37-43
Grzanna, R.; Coyle, J.T. 1978: Dopamine-beta-hydroxylase in rat submandibular ganglion cells which lack norepinephrine. Brain Research 151(1): 206-214
De Potter, W.P.; De Potter, R.W.; De Smet, F.H.; Fraeyman, N.N. 1978: Dopamine-beta-hydroxylase in the cerebrospinal fluid and central noradrenergic activity. a pharmacological approach. Archives Internationales de Pharmacodynamie et de Therapie 232(2): 334-335
Lerner, P.; Goodwin, F.K.; van Kammen, D.P.; Post, R.M.; Major, L.F.; Ballenger, J.C.; Lovenberg, W. 1978: Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients. Biological Psychiatry 13(6): 685-694
Major, L.F.; Lerner, P.; Ballenger, J.C.; Brown, G.L.; Goodwin, F.K.; Lovenberg, W. 1979: Dopamine-beta-hydroxylase in the cerebrospinal fluid: relationship to disulfiram-induced psychosis. Biological Psychiatry 14(2): 337-344
Smythe, G.A.; Bradshaw, J.E.; Gleeson, R.M.; Nicholson, M.V. 1985: Dopamine-beta-hydroxylase inhibition acutely stimulates rats hypothalamic noradrenaline and dopamine neuronal activity as assessed from metabolic ratios and circulating glucose and ACTH responses. Life Sciences 37(9): 841-847
Blaustein, J.D.; Brown, T.J.; Swearengen, E.S. 1986: Dopamine-beta-hydroxylase inhibitors modulate the concentration of functional estrogen receptors in female rat hypothalamus and pituitary gland. Neuroendocrinology 43(2): 150-158
Evans, K.R.; Beninger, R.J.; Eikelboom, R. 1985: Dopamine-beta-hydroxylase inhibitors, feeding and locomotor activity: reinstatement of feeding following central norepinephrine. Pharmacology Biochemistry and Behavior 22(4): 535-540
Planz, G.; Planz, R. 1979: Dopamine-beta-hydroxylase, adrenaline, noradrenaline and dopamine in the venous blood of adrenal gland of man: a comparison with levels in the periphery of the circulation. Experientia 35(2): 207-208
Kafka, M.S.; Blumenthal, R.; Walker, G.A.; Pollard, H.B. 1978: Dopamine-beta-hydroxylase-induced changes in the electrical conductance of bimolecular lipid membranes. Membrane Biochemistry 1(3-4): 279-295
Klemm, N.; Nässel, D.R.; Osborne, N.N. 1985: Dopamine-beta-hydroxylase-like immunoreactive neurons in two insect species, Calliphora erythrocephala and Periplaneta americana. Histochemistry 83(2): 159-164
Adeghate, E.; Donáth, T. 1991: Dopamine-beta-hydroxylase-positive nerves in normal and transplanted pancreatic tissue in the anterior eye-chamber of rats. Journal of Chemical Neuroanatomy 4(3): 223-227
Stone, R.A. 1975: Dopamine-beta-hydroxylase. An index of adrenergic function in hypertensive patients. Western Journal of Medicine 123(2): 108-114
Sokoloff, R.L.; Frigon, R.P.; O'Connor, D.T. 1985: Dopamine-beta-hydroxylase: structural comparisons of membrane-bound versus soluble forms from adrenal medulla and pheochromocytoma. Journal of Neurochemistry 44(2): 411-420
Okada, F. 1975: Dopamine-beta-hydroxylast and the function of the nervous system. Hokkaido Journal of Medical Science 50(3): 342-343
Holmes, L.J.; Wise, R.A. 1985: Dopamine-dependent contralateral circling induced by neurotensin applied unilaterally to the ventral tegmental area in rats. Brain Research Bulletin 15(5): 537-538
Sivam, S.P.; Krause, J.E.; Breese, G.R.; Hong, J.S. 1991: Dopamine-dependent postnatal development of enkephalin and tachykinin neurons of rat basal ganglia. Journal of Neurochemistry 56(5): 1499-1508
Galzigna, L.; Fasolato, C.; Bianchi, M.; Burlina, A.P.; Previero, A. 1988: Dopamine-depleting activity of L-3,4-(dioxyphenylacetyl)-phenylalanine. Neuropsychobiology 19(4): 180-185
Dostert, P.; Strolin Benedetti, M.; Dordain, G. 1988: Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases. Journal of Neural Transmission 74(2): 61-74
Di Loreto, S.; Florio, T.; Scarnati, E. 1989: Dopamine-glutamate interaction and cholinesterase activity in the corpus striatum of the adult rat. Bollettino della Societa Italiana di Biologia Sperimentale 65(9): 893-900
Matsumoto, R.R.; Lohof, A.M.; Patrick, R.L.; Walker, J.M. 1988: Dopamine-independent motor behavior following microinjection of rimorphin in the substantia nigra. Brain Research 444(1): 67-74
Kollár, A.; Kékesi, V.; Juhász-Nagy, A. 1991: Dopamine-induced aggravation of myocardial ischaemia in the paced heart: cardiosurgical perspectives. Acta Chirurgica Hungarica 32(3): 237-244
Bloom, G.D.; Carlsöö, B.; Danielsson, A. 1975: Dopamine-induced amylase secretion from guinea-pig submandibular gland. British Journal of Pharmacology 54(4): 523-528
Hata, F.; Ishida, H.; Kondo, E. 1986: Dopamine-induced amylase secretion from rat parotid salivary gland in vitro: an effect mediated via noradrenergic and cholinergic nerves. British Journal of Pharmacology 89(3): 473-483
Oliveira, A.M.; Bendhack, L.M. 1992: Dopamine-induced contractile responses of the rat anococcygeus muscle. Archives Internationales de Pharmacodynamie et de Therapie 316: 97-104
Rabloczky, G.; Kékesi, V.; Mader, M.R.; Juhász-Nagy, A. 1988: Dopamine-induced coronary effects in the dog heart attributed to beta- and alpha-adrenergic mechanisms. Archives Internationales de Pharmacodynamie et de Therapie 293: 109-126
Bell, C.; Matalanis, G. 1977: Dopamine-induced depression of adrenergic nerve-mediated contraction of smooth muscle. British Journal of Pharmacology 61(2): 291-295
Johannesen, J.; Lie, M.; Mathisen, O.; Kiil, F. 1976: Dopamine-induced dissociation between renal metabolic rate and sodium reabsorption. American Journal of Physiology 230(4): 1126-1131
Chneiweiss, H.; Glowinski, J.; Premont, J. 1990: Dopamine-induced homologous and heterologous desensitizations of adenylate cyclase-coupled receptors on striatal neurons. European Journal of Pharmacology 189(4-5): 287-292
Gelfman, D.M.; Ornato, J.P.; Gonzalez, E.R. 1987: Dopamine-induced increase in atrioventricular conduction in atrial fibrillation-flutter. Clinical Cardiology 10(11): 671-673
Valentijn, J.A.; Louiset, E.; Vaudry, H.; Cazin, L. 1991: Dopamine-induced inhibition of action potentials in cultured frog pituitary melanotrophs is mediated through activation of potassium channels and inhibition of calcium and sodium channels. Neuroscience 42(1): 29-39
Ross, M. 1991: Dopamine-induced localized cutaneous vasoconstriction and piloerection. Archives of Dermatology 127(4): 586-587
Marzio, L.; Neri, M.; Di Giammarco, A.M.; Cuccurullo, F.; Lanfranchi, G.A. 1986: Dopamine-induced migrating myoelectrical complex-like activity in human duodenum. Digestive Diseases and Sciences 31(4): 349-354
Bogaert, M.G.; Schaepdryver, A.F.; Willems, J.L. 1977: Dopamine-induced neurogenic vaso-dilatation in the intact hindleg of the dog. British Journal of Pharmacology 59(2): 283-292
Willems, J.L.; Bogaert, M.G. 1975: Dopamine-induced neurogenic vasodilatation in isolated perfused muscle preparation of the dog. Naunyn-Schmiedeberg's Archives of Pharmacology 286(4): 413-428
Reifel, C.W.; Shin, S.H.; Saunders, S.L. 1985: Dopamine-induced physical barrier to inhibit prolactin release in mammotrophs disappears during resumption of prolactin secretion. Neuroendocrinology 40(5): 438-443
Satake, N.; Ueda, S.; Shibata, S. 1985: Dopamine-induced potentiation of the contractile response to arachidonic acid in guinea-pig aorta. General Pharmacology 16(4): 391-393
Yamauchi, M.; Kobayashi, Y.; Hattori, K.; Yamada, K.; Nakase, A. 1989: Dopamine-induced relaxation in human pulmonary arteries. Experientia 45(2): 150-152
Lucchelli, A.; Boselli, C.; Grana, E. 1990: Dopamine-induced relaxation of the guinea-pig isolated jejunum is not mediated through dopamine receptors. Pharmacological Research 22(4): 433-444
Kohno, Y.; Nomura, Y.; Segawa, T. 1985: Dopamine-induced up-regulation of alpha 2-adrenoceptors in crude synaptic membranes of rat brain. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 85(3): 173-183
Lapin, E.P.; Maker, H.S.; Sershen, H.; Hurd, Y.; Lajtha, A. 1987: Dopamine-like action of nicotine: lack of tolerance and reverse tolerance. Brain Research 407(2): 351-363
Worms, P.; Kan, J.P.; Wermuth, C.G.; Biziere, K. 1986: Dopamine-like activities of an aminopyridazine derivative, CM 30366: a behavioural study. Naunyn-Schmiedeberg's Archives of Pharmacology 334(3): 246-252
Crumly, H.J.; Pinder, R.M.; Hinshaw, W.B.; Goldberg, L.I. 1976: Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene. Nature 259(5544): 584-587
Singh, N.A.; Bush, L.G.; Gibb, J.W.; Hanson, G.R. 1990: Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors. European Journal of Pharmacology 187(3): 337-344
Nishida, S.; Matsuki, M.; Horino, M.; Kawai, Y.; Tsushima, K.; Yoneda, M.; Oyama, H.; Ishii, R. 1990: Dopamine-mediated effects induced by metoclopramide simultaneously on adrenocorticotropic hormone and prolactin in patients with pituitary and/or hypothalamic disorders. Clinica Chimica Acta; International Journal of Clinical Chemistry 190(3): 269-275
Ritter, J.K.; Schmidt, C.J.; Gibb, J.W.; Hanson, G.R. 1985: Dopamine-mediated increases in nigral substance P-like immunoreactivity. Biochemical Pharmacology 34(17): 3161-3166
Schorderet, M. 1978: Dopamine-mimetic activity of ergot derivatives, as measured by the production of cyclic AMP in isolated retinae of the rabbit. Gerontology 24(Suppl 1): 86-93
Schorderet, M.; McDermed, J. 1978: Dopamine-mimetic activity of some aminotetralins, as revealed by the production of cyclic AMP in rabbit retina in vitro. Advances in Biochemical Psychopharmacology 19: 351-355
Nobrega, J.N.; Coscina, D.V. 1986: Dopamine-norepinephrine interactions in the development of hyperphagia and obesity following medial hypothalamic lesions. Pharmacology Biochemistry and Behavior 25(2): 401-409
Bivins, B.A.; Rapp, R.P.; Griffen, W.O.; Blouin, R.; Bustrack, J. 1978: Dopamine-phenytoin interaction. a cause of hypotension in the critically ill. Archives of Surgery 113(3): 245-249
Aldrich, M.S.; Hollingsworth, Z.; Penney, J.B. 1992: Dopamine-receptor autoradiography of human narcoleptic brain. Neurology 42(2): 410-415
Antelman, S.M.; Herndon, J.G.; Caggiula, A.R.; Shaw, D.H. 1975: Dopamine-receptor blockade: prevention of shock-activated sexual behavior in naive rats. Psychopharmacology Bulletin 11(3): 45-46
Walaas, S.I.; Sedvall, G.; Greengard, P. 1989: Dopamine-regulated phosphorylation of synaptic vesicle-associated proteins in rat neostriatum and substantia nigra. Neuroscience 29(1): 9-19
Ouimet, C.C.; Hemmings, H.C.; Greengard, P. 1988: Dopamine-regulated protein phosphorylation in the basal ganglia. Advances in Experimental Medicine and Biology 235: 1-17
Flis, R.S.; Scoblionco, D.P.; Bastl, C.P.; Popovtzer, M.M. 1977: Dopamine-related polyuria in patients with gram-negative infection. Archives of Internal Medicine 137(11): 1547-1550
Sirinathsinghji, D.J.; Heavens, R.P.; McBride, C.S. 1988: Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Brain Research 443(1-2): 101-116
Lauterbach, E.C.; Spears, T.E.; Prewett, M.J. 1990: Dopamine-responsive dysnomia?. Journal of Neuropsychiatry and Clinical Neurosciences 2(3): 353-354
Dunnett, S.B.; Whishaw, I.Q.; Rogers, D.C.; Jones, G.H. 1987: Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions. Brain Research 415(1): 63-78
Proye, C.; Fossati, P.; Fontaine, P.; Lefebvre, J.; Decoulx, M.; Wemeau, J.L.; Dewailly, D.; Rwamasirabo, E.; Cecat, P. 1986: Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 100(6): 1154-1162
Riederer, P.; Rausch, W.D.; Birkmayer, W.; Jellinger, K.; Danielczyk, W. 1978: Dopamine-sensitive adenylate cyclase activity in the caudate nucleus and adrenal medulla in Parkinson's disease and in liver cirrhosis. Journal of Neural Transmission. Supplementum 14: 153-161
Shibuya, M. 1979: Dopamine-sensitive adenylate cyclase activity in the striatum in Parkinson's disease. Journal of Neural Transmission 44(4): 287-295
Traficante, L.J.; Friedman, E.; Oleshansky, M.A.; Gershon, S. 1976: Dopamine-sensitive adenylate cyclase and cAMP phosphodiesterase in substantia nigra and corpus striatum of rat brain. Life Sciences 19(7): 1061-1066
Krueger, B.K.; Forn, J.; Greengard, P. 1975: Dopamine-sensitive adenylate cyclase and protein phosphorylation in the rat caudate nucleus. Psychopharmacology Bulletin 11(4): 10-11
Seeber, U.; Kuschinsky, K. 1976: Dopamine-sensitive adenylate cyclase in homogenates of rat striata during ethanol and barbiturate withdrawal. Archives of Toxicology 35(4): 247-253
Amenta, F. 1985: Dopamine-sensitive adenylate cyclase in rabbit portal vein. Neuroscience Letters 56(3): 279-282
Nakajima, T.; Naitoh, F.; Kuruma, I. 1977: Dopamine-sensitive adenylate cyclase in the rat kidney particulate preparation. European Journal of Pharmacology 41(2): 163-169
Spano, P.F.; Kumakura, K.; Trabucchi, M. 1976: Dopamine-sensitive adenylate cyclase in the retina: a point of action for D-LSD. Advances in Biochemical Psychopharmacology 15: 357-365
Kebabian, J.W.; Saavedra, J.M. 1976: Dopamine-sensitive adenylate cyclase occurs in a region of substantia nigra containing dopaminergic dendrites. Science 193(4254): 683-685
Clouet, D.H.; Iwatsubo, K. 1975: Dopamine-sensitive adenylate cyclase of the caudate nucleus of rats treated with morphine. Life Sciences 17(1): 35-40
Krieger, N.R.; Kauer, J.S.; Shepherd, G.M.; Greengard, P. 1977: Dopamine-sensitive adenylate cyclase within laminae of the olfactory tubercle. Brain Research 131(2): 303-312
Carenzi, A.; Gillin, J.C.; Guidotti, A.; Schwartz, M.A.; Trabucchi, M.; Wyatt, R.J. 1975: Dopamine-sensitive adenylyl cyclase in human caudate nucleus. a study in control subjects and schizophrenic patients. Archives of General Psychiatry 32(8): 1056-1059
Oades, R.; Taghzouti, K.; Simon, H.; Le Moal, M. 1985: Dopamine-sensitive alternation and collateral behaviour in a Y-maze: effects of d-amphetamine and haloperidol. Psychopharmacology 85(1): 123-128
Turski, L.; Cavalheiro, E.A.; Bortolotto, Z.A.; Ikonomidou-Turski, C.; Kleinrok, Z.; Turski, W.A. 1988: Dopamine-sensitive anticonvulsant site in the rat striatum. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 8(11): 4027-4037
Stafford, K.J.; Leek, B.F. 1988: Dopamine-sensitive receptors that evoke rumination and modify reticulo-ruminal activity in sheep. Journal of Veterinary Pharmacology and Therapeutics 11(2): 171-176
Kuchel, O.; Buu, N.T.; Unger, T. 1978: Dopamine-sodium relationship: is dopamine a part of the endogenous natriuretic system?. Contributions to Nephrology 13: 27-36
Northington, F.K.; Hamill, R.W.; Banerjee, S.P. 1985: Dopamine-stimulated adenylate cyclase and tyrosine hydroxylase in diabetic rat retina. Brain Research 337(1): 151-154
Ferré, F. 1986: Dopamine-stimulated adenylate cyclase in human term placenta. Life Sciences 39(20): 1893-1900
Lössner, B.; Linke, I.; Eppendorfer, B.; Jork, R. 1985: Dopamine-stimulated fucosylation of brain proteins in vitro is not inhibited by puromycin. Biomedica Biochimica Acta 44(3): 465-473
Hanley, D.A.; Wellings, P.G. 1985: Dopamine-stimulated parathyroid hormone release in vitro: further evidence for a two-pool model of parathyroid hormone secretion. Canadian Journal of Physiology and Pharmacology 63(9): 1139-1144
Brown, G.M.; Seeman, P.; Lee, T. 1976: Dopamine/neuroleptic receptors in basal hypothalamus and pituitary. Endocrinology 99(5): 1407
Szabo, B.; Hedler, L.; Starke, K. 1986: Dopamine1 receptor agonist and alpha-2 adrenoceptor antagonist effects of fenoldopam in rabbits. Journal of Pharmacology and Experimental Therapeutics 239(3): 881-886
Felder, R.A.; Jose, P.A. 1988: Dopamine1 receptors in rat kidneys identified with 125I-Sch 23982. American Journal of Physiology 255(5 Part 2): F970-F976
Ortola, F.V.; Seri, I.; Downes, S.; Brenner, B.M.; Ballermann, B.J. 1990: Dopamine1-receptor blockade inhibits ANP-induced phosphaturia and calciuria in rats. American Journal of Physiology 259(1 Part 2): F138-F146
Wick, M.M. 1978: Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. Journal of Investigative Dermatology 71(2): 163-164
Prasad, A.L.; Fahn, S.; Isgreen, W.P. 1975: Dopamine: a sensitive automated assay and examples of levodopa therapy. Biochemical Medicine 14(1): 24-32
Kohli, J.D.; Goldberg, L.I. 1992: Dopamine: contributions and legacy of Leon I. Goldberg (1927-1989). Neurochemistry International 20 Suppl: 5s-8s
Mills, A. 1992: Dopamine: from Cinderella to Holy Grail. Trends in Pharmacological Sciences 13(11): 399-400
Dipalma, J.R. 1975: Dopamine: new uses for an old drug. American Family Physician 11(4): 149-151
Johansson, A.M.; Karlén, A.; Grol, C.J.; Sundell, S.; Kenne, L.; Hacksell, U. 1986: Dopaminergic 2-aminotetralins: affinities for dopamine D2-receptors, molecular structures, and conformational preferences. Molecular Pharmacology 30(3): 258-269
Longoni, R.; Spina, L.; Di Chiara, G. 1987: Dopaminergic D-1 receptors: essential role in morphine-induced hypermotility. Psychopharmacology 93(3): 401-402
Augood, S.J.; Kiyama, H.; Faull, R.L.; Emson, P.C. 1991: Dopaminergic D1 and D2 receptor antagonists decrease prosomatostatin mRNA expression in rat striatum. Neuroscience 44(1): 35-44
Lamprecht, F. 1977: Dopaminergic Neurotransmission in Parkinson's syndrome. Fortschritte der Neurologie Psychiatrie und Ihrer Grenzgebiete 45(8): 459-471
Iimura, O.; Shimamoto, K.; Ura, N. 1990: Dopaminergic activity and water-sodium handling in the kidneys of essential hypertensive subjects: is renal dopaminergic activity suppressed at the prehypertensive stage?. Journal of Cardiovascular Pharmacology 16(Suppl 7): S56-S58
Piazza, P.V.; Rougé-Pont, F.; Deminière, J.M.; Kharoubi, M.; Le Moal, M.; Simon, H. 1991: Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Research 567(1): 169-174
Cheng, H.C.; Long, J.P.; Van Orden, L.S.; Cannon, J.G.; O'Donnell, J.P. 1976: Dopaminergic activity of some apomorphine analogs. Research Communications in Chemical Pathology and Pharmacology 15(1): 89-106
Dankova, J.; Bédard, P.; Langelier, P.; Poirier, L.J. 1978: Dopaminergic agents and circling behaviour. General Pharmacology 9(5): 295-302
Autelitano, D.J.; Smith, A.I.; Lolait, S.J.; Funder, J.W. 1985: Dopaminergic agents differentially alter beta-endorphin processing patterns in the rat pituitary neurointermediate lobe. Neuroscience Letters 59(1): 141-146
Smith, A.I.; Wallace, C.A.; Clarke, I.J.; Funder, J.W. 1989: Dopaminergic agents differentially regulate both processing and content of alpha-N-acetylated endorphin and alpha-MSH in the ovine pituitary intermediate lobe. Neuroendocrinology 49(5): 545-550
Vincent, J.L. 1991: Dopaminergic agents in vital organ perfusion. Intensive Care Medicine 17(4): 246-247
Gower, A.J.; Broekkamp, C.L. 1985: Dopaminergic agents including 3-PPP and its enantiomers on medial septal self-stimulation. Pharmacology Biochemistry and Behavior 22(2): 309-315
Millington, W.R.; O'Donohue, T.L.; Mueller, G.P. 1987: Dopaminergic agents selectively alter the post-translational processing of beta-endorphin in the intermediate pituitary of the rat. Journal of Pharmacology and Experimental Therapeutics 243(1): 160-170
Birket-Smith, E.; Bøttcher, J.; Dupont, E.; Holm, P.; Jensen, J.P.; Kristensen, O.; Køhler, O.; Mikkelsen, B. 1978: Dopaminergic agonist Ro 8-4650 in Parkinson's disease. I. Patients treated with dopa. Acta Neurologica Scandinavica 58(1): 74-76
Presthus, J.; Ankerhus, J.; Burén, A.; Bøttcher, J.; Holmsen, R.; Mikkelsen, B.; Mikkelsen, B.O.; Nyberg-Hansen, R.; Riman, E.; Severin, B.; Aarli, J.A. 1978: Dopaminergic agonist Ro 8-4650 in Parkinson's disease. II. Patients not treated with dopa. Acta Neurologica Scandinavica 58(1): 77-79
Rinne, U.K.; Sonninen, V.; Marttila, R. 1975: Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism. Advances in Neurology 9: 383-392
Grof, P.; Saxena, B.; Daigle, L.; Mahutte, G. 1977: Dopaminergic agonist nomifensine compared with amitriptyline: a double-blind clinical trial in acute primary depressions. British Journal of Clinical Pharmacology 4suppl 2: 221s-225s
Angrist, B.; Rotrosen, J.; Kleinberg, D.; Merriam, V.; Gershon, S. 1977: Dopaminergic agonist properties of ephedrine--theoretical implications. Psychopharmacology 55(2): 115-120
Lisoprawski, A.; Jouvent, R. 1989: Dopaminergic agonists and affective dullness. L'Encephale 15(Special Issue): 197-200
Dubois, B.; Agid, Y. 1986: Dopaminergic agonists in Parkinson disease. La Revue du Praticien 36(5): 207-214
Goetz, C.G.; Diederich, N.J. 1992: Dopaminergic agonists in the treatment of Parkinson's disease. Neurologic Clinics 10(2): 527-540
Carvey, P.M.; Kao, L.C.; Zhang, T.J.; Amdur, R.L.; Lin, D.H.; Singh, R.; Klawans, H.L. 1990: Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacology Biochemistry and Behavior 35(2): 291-300
Van der Laan, J.W. 1987: Dopaminergic and alpha 1-adrenergic properties of B-HT920 revealed in morphine-dependent rats. Pharmacology Biochemistry and Behavior 26(2): 265-269
Lindley, S.E.; Lookingland, K.J.; Moore, K.E. 1990: Dopaminergic and beta-adrenergic receptor control of alpha-melanocyte-stimulating hormone secretion during stress. Neuroendocrinology 52(1): 46-51
Glick, S.D.; Cox, R.D. 1975: Dopaminergic and cholinergic influences on morphine self-administration in rats. Research Communications in Chemical Pathology and Pharmacology 12(1): 17-24
Delitala, G.; Palermo, M.; Ross, R.; Coy, D.; Besser, M.; Grossman, A. 1987: Dopaminergic and cholinergic influences on the growth hormone response to growth hormone-releasing hormone in man. Neuroendocrinology 45(3): 243-247
Hall, R.C.; Keane, P.E. 1975: Dopaminergic and cholinergic interactions in the caudate nucleus in relation to the induction of sleep in the cat. British Journal of Pharmacology 54(2): 247P-248P
Wässle, H.; Chun, M.H. 1988: Dopaminergic and indoleamine-accumulating amacrine cells express GABA-like immunoreactivity in the cat retina. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 8(9): 3383-3394
Power, R.F.; Mani, S.K.; Codina, J.; Conneely, O.M.; O'Malley, B.W. 1991: Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254(5038): 1636-1639
Stevens, K.E.; Fuller, L.L.; Rose, G.M. 1991: Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating. Brain Research 555(1): 91-98
Harris, T.; Muller, B.; Cotton, R.G.; Borri Voltattorni, C.; Bell, C. 1986: Dopaminergic and noradrenergic sympathetic nerves of the dog have different DOPA decarboxylase activities. Neuroscience Letters 65(2): 155-160
Szostak, C.; Jakubovic, A.; Phillips, A.G.; Fibiger, H.C. 1986: Dopaminergic and serotonergic correlates of stimulation-induced circling. Behavioural Brain Research 21(1): 37-46
Halmi, K.; Sherman, B.S. 1977: Dopaminergic and serotonergic regulation of growth hormone secretion in anorexia nervosa. Psychopharmacology Bulletin 13(1): 63-65
Carruba, M.O.; Ricciardi, S.; Spano, P.; Mantegazza, P. 1985: Dopaminergic and serotoninergic anorectics differentially antagonize insulin- and 2-DG-induced hyperphagia. Life Sciences 36(18): 1739-1749
Frey, U.; Schroeder, H.; Matthies, H. 1990: Dopaminergic antagonists prevent long-term maintenance of posttetanic LTP in the CA1 region of rat hippocampal slices. Brain Research 522(1): 69-75
Ginos, J.Z.; Doroski, D. 1979: Dopaminergic antagonists: effects of 1,2,3,4-tetrahydroisoquinoline and its N-methyl and N-propyl homologs on apomorphine- and L-dopa-induced behavioral effects in rodents. Journal of Pharmacology and Experimental Therapeutics 209(1): 79-86
Carlsson, A. 1977: Dopaminergic autoreceptors: background and implications. Advances in Biochemical Psychopharmacology 16: 439-441
Kubota, Y.; Inagaki, S.; Kito, S.; Wu, J.Y. 1987: Dopaminergic axons directly make synapses with GABAergic neurons in the rat neostriatum. Brain Research 406(1-2): 147-156